eMedicine Specialties > Neurology > Headache and Pain
Pathophysiology of Chronic Back Pain
Updated: Jun 30, 2009
Introduction
Chronic low back pain (LBP) is the most expensive benign condition in industrialized countries and the most common cause of activity limitation in persons younger than 45 years. It is defined as pain that persists longer than 12 weeks and is often attributed to degenerative or traumatic conditions of the spine. Fibrositis, inflammatory spondyloarthropathy, and metabolic bone conditions are also cited as causes. Although acute LBP has a favorable prognosis, the effect of chronic LBP and its related disability on society is tremendous. Unlike acute LBP, chronic LBP serves no biologic purpose. However, it is a disorder that evolves in a complex milieu influenced by endogenous and exogenous factors, and it alters the individual's productivity to an extent beyond what the initiating pathologic dysfunction would have.
Background
Approximately 80% of Americans experience LBP during their lifetime. An estimated 15-20% develop protracted pain, and approximately 2-8% have chronic pain. Every year, 3-4% of the population is temporarily disabled, and 1% of the working-age population is disabled totally and permanently because of LBP. LBP is second only to the common cold as a cause of lost work time; it is the fifth most frequent cause for hospitalization and the third most common reason to undergo a surgical procedure. Productivity losses from chronic LBP approach $28 billion annually in the United States.
LBP is defined as chronic after 3 months because most normal connective tissues heal within 6-12 weeks unless pathoanatomic instability persists. A slowed rate of tissue repair in the relatively avascular intervertebral disk may impair the resolution of chronic LBP.
Traumatic or degenerative conditions of the spine are the most common causes of chronic LBP. Although disk protrusion and herniation have been popularized as causes of LBP and sciatica, asymptomatic disk herniations on CT and MRI are common. Furthermore, the relationship between the extent of disk protrusion and the degree of clinical symptoms is not clear. A strictly mechanical or pathoanatomic explanation for LBP and sciatica has proved inadequate; therefore, the role of biochemical and inflammatory factors remains under investigation. In fact, this failure of the pathologic model to predict back pain often leads to an ironic predicament for the patient with LBP.
If diagnostic studies are unrevealing of a structural cause, physicians and patients alike question whether the pain has a psychologic, rather than physical, cause. Physical and nonphysical factors, interwoven in a complex fashion, influence the transition from acute to chronic LBP. The identification of all contributing physical and nonphysical factors enables the treating physician to enact a comprehensive approach with the best likelihood for success.
Epidemiology
The estimated yearly prevalence of LBP is 5-20% in the United States and 25-45% in Europe. About 2% of American workers have compensable back injuries each year, ie, a staggering 500,000 cases of work-related spinal injuries. LBP accounts for 19% of all Workers' Compensation claims in the United States. According to the Bureau of Labor and Statistics, metal workers generated 76% of all claims of back strain and/or sprains in the United States. Jobs that require manual-handling activities accounted for more than half of all back pain reports. Injuries to the back were highest among truck drivers, operators of heavy equipment, and construction workers.
An estimated 4.1 million Americans had symptoms of an intervertebral disk disorder between 1985 and 1988, with an annual prevalence of about 2% in men and 1.5% in women. A study of 295 Finnish concrete workers aged 15-64 years revealed that 42% of men, and as many as 60% of those aged 45 years or older, reported having sciatica. When interviewed approximately 5 years later, the lifetime prevalence had increased from 42% to 59%.
Sciatica due to lumbar intervertebral disk herniations usually resolves with conservative treatment. However, it leads to surgery more often than does back pain alone. In a published review of more than 15,000 disk operations, the most common surgical level was L4-5 (49.8%), followed by L5-S1 (46.9%); only 3.4% were performed at levels higher than these. Surgical treatment for lumbar diskogenic syndromes is most common in the United States, where the estimated rate is at least 40% higher than that of in other countries and more than 5 times higher than rates in Scotland and England.
In the United States, the estimated cost of LBP in 1980 was $85 million dollars. Between 1971 and 1981, the number of Americans disabled by LBP grew at 14 times the rate of population growth. Resultant disability in Western culture has reached endemic proportions, with enormous socioeconomic consequences.
LBP is most prevalent in industrialized societies. Genetic factors that predispose persons of specific ethnicity or race to this disorder have not been clearly identified with respect to mechanical, diskogenic, or degenerative causes. Men and women are affected equally, but in those older than 60 year, women report low-back symptoms more often than men.
The incidence of LBP peaks in middle age and declines in old age, when degenerative changes of the spine are universal. Sciatica usually occurs in patients during the fourth and fifth decades of life; the average age of patients who undergo lumbar diskectomy is 42 years.
Pathophysiology
Degenerative cascade
The lumbar spine forms the caudal flexible portion of an axial structure that supports the head, upper extremities, and internal organs over a bipedal stance. The sacrum forms the foundation of the spine through which it articulates with the sacroiliac joints to the pelvis. The lumbar spine can support heavy loads in relationship to its cross-sectional area. It resists anterior gravitational movement by maintaining lordosis in a neutral posture.
Unlike the thoracic spine, the lumbar spine is unsupported laterally and had considerable mobility in both the sagittal and coronal planes. The bony vertebrae act as specialized structures to transmit loads through the spine. Parallel lamellae of highly vascularized cancellous bone form trabeculae, which are oriented along lines of biomechanical stress and encapsulated in a cortical shell. Vertebral bodies progressively enlarge in cross-sectional area because gravitational loads increase from cephalic to caudal segments. Bony projections from the lumbar vertebra, including the transverse processes and spinous processes, maintain ligamentous and muscular connections to the segments above and below them.
The intervertebral disk is composed of the outer annulus fibrosis and the inner nucleus pulposus. The outer portion of the annulus inserts into the vertebral body and accommodates nociceptors and proprioceptive nerve endings. The inner portion of the annulus encapsulates the nucleus, providing the disk with extra strength during compression. The nucleus pulposus of a healthy intervertebral disk constitutes two thirds of the surface area of the disk and supports more than 70% of the compressive load.
The nucleus is composed of proteoglycan megamolecules can imbibe water to a capacity approximately 250% of their weight. Until the third decade of life, the gel of the inner nucleus pulposus is composed of approximately 90% water; however, the water content gradually diminishes over the next 4 decades to approximately 65%. Nutrition to the inner annulus fibrosis and nucleus pulposus depends on the diffusion of water and small molecular substances across the vertebral endplates because only the outer third of the annulus receives blood supply from the epidural space.
Repeated eccentric and torsional loading and recurrent microtrauma results in circumferential and radial tears in annular fibers. Some annular tears may cause endplate separation, which results in additional loss of nuclear nutrition and hydration. Coalescence of circumferential tears into radial tears may allow nuclear material to migrate out of the annular containment into the epidural space and cause nerve root compression or irritation.
Throughout youth (at least the first 2 decades), 80-90% of the weight of the trijoint complex of the lumbar spine is transmitted across the posterior third of the disk; however, as disk height decreases and the biomechanical axis of loading shifts posteriorly, the posterior articulations (ie, facet joints) bear greater percentages of the weight distribution. Bone growth (osteophytes) compensates for this increased biomechanical stress to stabilize the trijoint complex.
Over time, hypertrophy of the facets and bony overgrowth of the vertebral endplates contribute to progressive foraminal and central canal narrowing. In addition to relative thickening of the ligament flavum and disk herniation, these changes contribute to reduction of the anteroposterior canal diameter and foraminal patency with neural compression. Spinal stenosis reaches a peak later in life and may produce radicular, myelopathic, or vascular syndromes such as pseudoclaudication and spinal cord ischemia.
LBP is most common in the early stages of disk degeneration, in what Kirkaldy-Willis called the stabilization phase. Impaired healing of the intervertebral disk due to its poor and peripheral blood supply serving only the external third of the outer annulus has been introduced as a possible explanation for the divergent behavior of this structure, which can produce chronic nociception. Also, elucidation of biochemical changes that may sensitize the disk and other structures capable of nociception within the trijoint construct may contribute to this discrepancy.
Types of Pain
Diskogenic pain
Many studies have demonstrated that the intervertebral disk and other structures of the spinal motion segment can cause pain.
Kuslich et al used regional anesthesia in 193 patients who were about to undergo lumbar decompressive surgery for disk herniation or spinal stenosis.1 Pain was elicited by using blunt surgical instruments or an electrical current of low voltage in 30% of patients who had stimulation of the paracentral annulus fibrosis and in 15% with stimulation of the central annulus fibrosis. However, it is unclear why mechanical back pain syndromes commonly become chronic, with pain persisting beyond the normal healing period for most soft-tissue or joint injuries in the absence of nonphysical or operant influences.
In 1987, Mooney proposed that this LBP chronicity was best explained by a tissue component of the spine that obeyed physiologic rules different from those of other connective tissues in the body.2 This divergent behavior is best illustrated in the intervertebral disk with its composition of large, unique, water-imbibing proteoglycan molecules. During adulthood, these large molecules break into small molecules that bind less water than the original molecule. Repair by means of proteoglycan synthesis is slow. Fissuring and disruption of annular lamellae further exacerbate molecular breakdown and dehydration of the disk. Arterial blood supply to the peripheral one third of the outer annulus is meager and inadequate to prevent subsequent internal degeneration.
The annulus and nucleus pulposus are similarly compromised, as they receive nutrition only by means of diffusion through adjacent vertebral endplates. Although sluggish healing of the intervertebral disk may partially account for the tendency of a spinal lesion to lead to chronicity, a direct concordance between structural degeneration and spinal pain does not exist.
Recent elucidation of biochemical behaviors and neurophysiologic factors affecting the disk and other regional pain-sensitive tissues may account for this discrepancy. In humans, painful disks have a lower pH than that of nonpainful disks. Also, experimental lowering of the pH in animal models induced pain-related behaviors and hyperalgesia. Diskography of canine disks that were normally or experimentally deformed seemed to show increased concentrations of neuropeptides, such as substance P (SP), calcitonin gene-related peptide (CGRP), and vasoactive intestinal peptide (VIP) in the dorsal root ganglion (DRG), implicating their possible role in the transmission or the modulation of pain. SP probably modulates initial nociceptive signals received in the gray matter of the dorsal spinal cord.
Somatostatin is another neuropeptide in dense concentration the dorsal gray of the spinal cord. Somatostatin is released from the DRG after noxious thermal stimulation and likely plays a role in pain transmission and in producing neurogenic inflammation. Therefore, the release of neuropeptides like SP, VIP, and CGRP may occur in response to noxious biochemical forces and environmental factors (eg, biomechanical stress, microtrauma, vibration), stimulating the synthesis of inflammatory agents (eg, cytokines, prostaglandin E2) and degradative enzymes (eg, proteases, collagenase). These factors cause progressive deterioration of the motion segment structures, especially the intervertebral disk.
Inflammatory factors may be responsible for pain in some cases in which epidural steroid injections provide relief. Corticosteroids inhibit the production of arachidonic acid and its metabolites (prostaglandins and leukotrienes), inhibiting phospholipase A2 (PLA2) activity. Levels of PLA2, which plays a role in inflammation, are elevated in surgically extracted samples of human herniated disks. Furthermore, PLA2 may play a dual role, inciting disk degeneration and sensitizing annular nerve fibers. Afferent nociceptors in nerve roots may be sensitive to various proinflammatory mediators, which are inhibited by corticosteroids, such as prostanoids produced from arachidonic acid and released from cell membrane phospholipids by PLA2.
Research suggests that proinflammatory cytokines may also contribute to diskogenic pain by sensitizing nociceptors and their effect on disk degeneration by suppressing proteoglycan synthesis and increased diskal matrix degradation. Cytokines are produced in response to neural injury in the CNS and may play a role in spinal neural hypersensitization and chronic neuropathic pain. Cytokines known to play a role in nociception include nerve growth factor, interleukin (IL)-1, IL-6, IL-10, and tumor necrosis factor-alpha (TNF-alpha).
Corticosteroids can inhibit activity of TNF-alpha, which induces IL-1 and prostaglandin E2 production. Once released, these substances contribute to early and late effects of the inflammatory process and stimulate nociception. A nociceptive role for nitric oxide (NO) in diskogenic pain syndromes is under investigation. NO levels are elevated in human disk herniations and when the hydrostatic pressure of the disk is increased due to biomechanical stressors. NO inhibits proteoglycan synthesis in cells in the nucleus pulposus, leading to proteoglycan loss, reduced water content, and disk degeneration.
Neurotransmitters and biochemical factors may sensitize neural elements in the motion segment so that the normal biomechanical stresses induced by previously asymptomatic movements or lifting tasks cause pain. Furthermore, injury and the consequential neurochemical cascade may initiate the degenerative and inflammatory changes described above, which mediate additional biochemical and morphologic changes and which modify or prolong the pain stimulus. Whether the biochemical changes that occur with disk degeneration are the consequence or cause of these painful conditions is unclear. However, chemical and inflammatory factors may create the environmental substrata through which biochemical stress and forces cause axial or limb pain with various characteristics and degrees.
Radicular pain
The pathophysiology of spinal nerve-root or radicular pain is unclear. Proposed etiologies include neural compression with axonal dysfunction, ischemia, inflammation, and biochemical influences. Spinal nerve roots have unique properties that may explain their proclivity to produce symptoms. Unlike peripheral nerves, spinal nerve roots lack a well-developed intraneural blood-nerve barrier, a lack which makes them more susceptible to symptomatic compression injury than peripheral nerves and vulnerable to endoneural edema formation.
Increased vascular permeability caused by mechanical nerve-root compression can induce endoneural edema. Furthermore, elevated endoneural fluid pressure due to intraneural edema can impede capillary blood flow and may cause intraneural fibrosis. Also, spinal nerve roots receive approximately 58% of their nutrition from surrounding CSF. Perineural fibrosis, which interferes with CSF-mediated nutrition, renders the nerve roots hyperesthetic and sensitive to compressive forces.
Research has elucidated several vascular mechanisms that can produce nerve-root dysfunction. Experimental nerve-root compression showed that venous blood flow can be stopped at low pressures, ie, 5-10 mm Hg. The occlusion pressure for radicular arterioles is substantially higher than this, approximating the mean arterial blood pressure and showing a correlation with systolic blood pressure; this factor increases the potential for venous stasis.
Some investigators postulate that venous then capillary stasis causes congestion that, in turn, may induce symptomatic nerve-root syndromes. Nerve-root ischemia or venous stasis may also generate pathologic biochemical changes that cause pain, unlike the progressive sensory then motor dysfunction typically seen with peripheral nerve compression. Studies of ischemia experimentally induced with low-pressure nerve-root compression demonstrated that compensatory nutrition from CSF diffusion is probably inadequate when epidural inflammation or fibrosis is present. Rapid onset of neural and vascular compromise is more likely than slow or gradual mechanical deformity to produce symptomatic radiculopathy.
Research has revealed other possible causative mechanisms for symptomatic radiculopathy. A 1987 animal study showed that autologous nucleus pulposus placed in the epidural space of dogs produced a marked epidural inflammatory reaction that did not occur in the comparison group, which received saline injections. Similar studies have shown myelin and axonal injury to nerve roots, as well as, reduced nerve conduction velocities exposed to autologous nucleus pulposus. Recent studies have demonstrated that experimental radicular exposure to degenerative nucleus pulposus and annulus fibrosis does not produce the same dysfunctional nerve-root changes. Cells of the nucleus pulposus can induce local neural dysfunction and generate algogenic agents, such as metalloprotease (eg, collagenase, gelatinase), as well as IL-6 and prostaglandin-E2.
Other biochemical substances, including TNF, have been implicated as causes. TNF increases vascular permeability and appears to be capable of inducing neuropathic pain. When injected into nerve fascicles, TNF produces changes similar to those seen when nerve roots are exposed to the nucleus pulposus. In addition, a still-unanswered issue is whether an autoimmune response occurs when nucleus pulposus is exposed to the systemic circulation because it is sequestered by the annulus fibrosis and because the immune system may not be recognized as normal. Indeed, research to date suggests that the cause of symptomatic radiculopathy is multifactorial and more complex than just neural dysfunction due to structural impingement.
Facet-joint pain
The superior and inferior articular processes of adjacent vertebral laminae form the facet or zygapophyseal joints, which are paired diarthrodial synovial articulations that share compressive loads and other biomechanical forces with the intervertebral disk. Like other synovial joints, the facets react to trauma and inflammation by manifesting pain, stiffness, and dysfunction with secondary muscle spasm leading to joint stiffness and degeneration. This process is borne out, as previously described, through the degenerative cascade of the trijoint complex. Numerous radiologic and histologic studies have shown that diskal and facet degeneration are linked and that, over time, degeneration of the segment leads to osteoarthritis of the facets.
Studies of provocative intra-articular injection techniques demonstrated local and referred pain into the head and upper extremities from cervical facets, into the upper midback and chest wall from thoracic facets, and into the lower extremity from the lumbar facets. The fibrous capsule of the facet joint contains encapsulated, unencapsulated, and free nerve endings.
Immunohistochemical studies have demonstrated nerve fibers containing neuropeptides that mediate and modulate nociception (eg, SP, CGRP, VIP). SP nerve fibers have been found in subchondral bone and degenerative lumbar facets subjected to aging and cumulative biomechanical loading. In fact, SP levels are correlated with the severity of joint arthritis. The infusion of SP into joints with mild disease reportedly accelerated the degenerative process. Furthermore, these chemicals and inflammatory mediators have been linked to proteolytic and collagenolytic enzymes that cause degradation of the cartilaginous matrix and osteoarthritis. Therefore, evidence of nociceptive afferents and the presence of algogenic neuropeptides, such as SP and CGRP, in facets and periarticular tissues support a role for these structures as spinal pain generators. Clinical research has demonstrated facet pain in 54-67% of patients with neck pain, 48% of patients with thoracic pain, and 15-45% of patients with LBP.
Sacroiliac pain
The sacroiliac joint is a diarthrodial synovial joint that receives its primary innervation from the dorsal rami of the first four sacral nerves. Arthrography or injection of irritant solutions into the sacroiliac joint provokes pain with variable local and referred pain patterns into regions of the buttock, lower lumbar area, lower extremity, and groin. Determined by using variety of blocking techniques, the reported prevalences of sacroiliac pain have been widely variable (2-30%) in patients evaluated for chronic LBP.
Muscular pain
Pain receptors in muscle are sensitive to a variety of mechanical stimuli, including pressure, pinching, cutting, and stretching. Pain and injury occur when the musculotendinous contractual unit is exposed to single or recurrent episodes of biomechanical overloading. Injured muscles are usually abnormally shortened, with increased tone and tension due to spasm or overcontraction. Injured muscles often meet diagnostic criteria for myofascial pain (MP) syndrome, a condition that Drs Janet Travell and David Simons originally described.
MP is characterized by muscles that are in a shortened or contracted state, with increased tone and stiffness, and that contain trigger points (TrPs). TrPs are tender, firm, 3- to 6-mm nodules that are identified on palpation of the muscles. TrP palpation provokes radiating, aching pain into localized reference zones. Mechanical stimulation of the taut band, a hyperirritable spot in the TrP, by needling or rapid transverse pressure often elicits a localized muscle twitch.
Sometimes, TrP palpation can elicit a jump sign, an involuntary reflex or flinching disproportionate to the palpatory pressure applied. MP may become symptomatic as a result of direct or indirect trauma, exposure to cumulative and repetitive strain, postural dysfunction and physical deconditioning. MP can occur at the site of tissue damage or due to radicular and other neuropathic disorders at sites where pain is referred. Muscles affected by neuropathic pain may be injured due to prolonged spasm, mechanical overload, or metabolic and nutritional shortfalls.
The pathogenesis of MP and TrPs remains unproven. To date, research suggests that myofascial dysfunction with characteristic TrPs is a spinal segmental reflex disorder. Animal studies showed that TrPs can be abolished by transecting efferent motor nerves or infusing of lidocaine; however, spinal transsection above the level of segmental innervation of a TrP-containing muscle does not alter the TrP response. Simons postulates that abnormal, persistently increased, and excessive acetylcholine release at the neuromuscular junction generates sustained muscle contraction and a continuous reverberating cycle. This cycle has been postulated to result in painful and dysfunctional extrafusal muscle contraction that forms the basis for MP and possibly the actual structural substrate of the TrP.
Neurophysiology of spinal pain and injury
Nociception is the neurochemical process whereby specific nociceptors convey pain signals through peripheral neural pathways to the CNS. In the setting of spinal injury, acute tissue damage to the spinal motion segment and associated soft tissues activates these pathways. When the peripheral source of pain persists, intrinsic mechanisms that reinforce nociception influence the pain. The nervous system can enhance a pain stimulus generated by tissue damage to levels far greater than any threat it signifies to the human organism; this is a common clinical scenario in cases of chronic spinal pain.
Peripheral transmission of pain stimuli through A-delta fibers and C-fibers leads to the release of excitatory amino acids, such as glutamine and asparagine, which then act on N -methyl-D-aspartic acid (NMDA) receptors, causing the release of the neuropeptide SP. Neuropeptides, such as SP, CGRP, and VIP are transported to the endings of nociceptive afferents, which inflammation and other algogenic mechanisms sensitize. These neurochemical changes exaggerated, adverse sensitize nociceptors so that they respond to mild or normal sensory stimuli, such as light touch or temperature change (allodynia).
Transduction is the process whereby noxious afferent stimuli are converted from chemical to electrical neural messages in the spinal cord that communicate cephalad to the brainstem, thalamus, and cerebral cortex. Noxious mechanical, thermal, and chemical stimuli activate peripheral nociceptors that transmit the pain message through lightly myelinated A-delta fibers and unmyelinated C-fibers. Nociceptors are present in the outer annular fibrosis, facet capsule, posterior longitudinal ligament, associated muscles, and other structures of the spinal motion segment.
Algogenic substances that are typically involved in tissue damage and that can induce peripheral transduction include potassium, serotonin, bradykinin, histamine, prostaglandins, leukotrienes, and SP. Transduction leads to transmission, which is the conduction of afferent pain signals to the DRG and dorsal horn of the spinal cord. The DRG contains cell bodies of primary afferent nociceptors, including the neuropeptides SP, VIP, and CGRP. The DRG is mechanically sensitive and capable of independent pain transduction, transmission, and modulation.
Nociceptive modulation first occurs in the dorsal horn, where nociceptive afferents converge to synapse on a single WDR neuron. WDR neurons respond with equal intensity regardless of whether the neural signal is noxious (hyperalgesia). Hyperalgesia and allodynia initially develop at the injury site; however, when central sensitization occurs by means of WDR neural activity, the area of pain expands beyond the initial region of tissue pathology.
Finally, a phenomenon termed wind-up results from repetitive activation of C-fibers sufficient to recruit second-order neurons that respond with progressively increasing magnitude; NMDA receptor antagonists can block this effect. Wind-up probably also contributes to CNS sensitization, including hyperalgesia, allodynia, and persistent pain. These nociceptive mechanisms, which reinforce the pain signal, frequently recruit sympathetic nervous system involvement. Elevated norepinephrine levels in injured areas increase pain sensitivity by means of regional vasomotor and sudomotor changes. Also, high acetylcholine levels can augment ongoing local and regional involuntary muscle contraction and spasm.
Evolutionary Mechanisms in Chronic LBP
Chronic LBP is not simply the same as acute LBP that persists for a greater duration. Usually 6-7 weeks is sufficient for healing to occur in most soft-tissue or joint injuries; however, 10% of LBP injuries do not resolve in this period. The evolution of chronic LBP is complex, with physiologic, psychological, and psychosocial influences. These influences can be divided into 3 major categories, with subcategories, as follows:
- Neurophysiological mechanisms
- Peripheral
- Peripheral to central
- Psychological mechanisms
- Behavioral
- Cognitive-affective
- Psychophysiological
- Barriers to recovery
- Medical and surgical
- Physical
- Psychological
- Neuropsychological
- Social
Neurophysiologic mechanisms
Peripheral mechanisms may reinforce nociception when the source of pain persists. If an ongoing pathologic condition causes the peripheral pain stimulus, continuous nociception may induce repetitive stimulation or sensitization of pain receptors and nerve fibers so that they adversely respond to even mild or normal sensory stimuli (ie, allodynia). Furthermore, liberation of algogenic and other substances from damaged tissues may induce changes in the microenvironment by means of neuroactive, biochemical, inflammatory, or vasoactive effects that activate or increase the sensitivity of nociceptors.
Peripheral-to-central processing may also modify nociception. Persistent tissue damage may stimulate afferent nerve fibers that project to internuncial neurons in the spinal cord and thereby set up neuronal loops of continuous self-sustaining abnormal reverberating nociceptive activity. Peripheral inhibition, a mechanism for reducing the intensity of an afferent pain signal, may be impaired owing to persistently malfunctioning or diseased large peripheral myelinated fibers, which normally dampen nociception (eg, peripheral neuropathy, epidural scarring, chronic herniated disk material).
Ectopic impulse generation is a theoretical mechanism Wall and Gutnick proposed.3 Damaged sensory nerves, such as neuromata or demyelinating lesions in peripheral nerves, produce aberrant signals. Deafferentation hypersensitivity also purportedly causes abnormal and chronic nociceptive firing patterns.
CNS bias of the signal may occur in the spinal cord, brainstem reticular formation, or cortex. The brainstem reticular formation acts to direct the attention of the CNS toward or away from central and peripheral stimuli. Depending on the degree of focus, or the lack thereof, transmission of pain signals may be enhanced or inhibited. Furthermore, cortical influences, such as cognitive and affective disorders, may affect the intensity of the processed pain signal.
Psychological mechanisms
Psychological manifestations are 3-fold; they include behavioral, cognitive-affective, and psychophysiological mechanisms. Guarded movement, nonverbal and verbal expression of pain, and inactivity are called pain behaviors. Normal well-behavior patterns may become extinguished when these verbal and nonverbal pain behaviors are reinforced by environmental factors.
Cognitive-affective mechanisms often contribute to the perception of chronic pain. Pain complaints are common in depressed individuals, and patients with chronic pain frequently become depressed. Depression acts though biochemical processes similar to those that are operative in chronic pain; this may enhance symptoms through a synergistic relationship. Depressed patients may illogically interpret and distort life experiences, further complicating the feasibility of treatment or employment.
Psychophysiologic mechanisms naturally triggered by pain and injury can lead to generalized muscle overactivity, increased fatigue, and other pain problems (eg, tension myalgia, headache). The emotional stress that pain induces tends to heighten norepinephrine activity and activity of the sympathetic nervous system, which may further amplify nociception by means of peripheral or central mechanisms.
Barriers to recovery
Barriers to recovery may be premorbid, caused by traumatic injury, or they develop over time as a result of psychological and environmental influences. These barriers strongly influence chronicity and the patient's prognosis. For example, medical problems, such as diabetes or heart disease, may make the patient a poor candidate for rehabilitation or surgery. Failed back surgery may create permanent physical and psychological impasses.
Patients differ in their inherent capacity to exercise. Deconditioning syndrome, a term Mayer coined, is caused by prolonged reduction of physical activity due to chronic LBP. This syndrome is associated with gradual reduction in muscle strength, joint mobility, and cardiovascular fitness, which over time may become a self-sustaining and independent component of the individual's musculoskeletal illness.
Preexisting psychological factors may combine with low back injuries to create a pain syndrome with predominantly psychiatric features. Psychiatric interviews of 200 patients with chronic LBP entering a functional restoration (FR) program revealed that 77% met lifetime diagnostic criteria for psychiatric syndromes, even when the category of somatoform pain disorder was excluded. In addition, 51% met criteria for at least 1 personality disorder.
Psychological barriers to recovery include those listed below.
- Premorbid factors
- Depression, dysthymia
- Predisposition to somatoform disorder
- Psychoactive substance-abuse disorder
- Personality disorder or traits
- Anxiety disorders including panic disorder
- Childhood sexual abuse
- Cognitive process
- Psychosis, delusional pain
- Traumatic factors
- Anxiety/panic
- Fear
- Psychophysiological response
- Loss of control
- Abnormal dependence
- Posttraumatic factors
- Anxiety, panic
- Depression
- Posttraumatic stress disorder
- Anger/hostility
- Iatrogenic substance abuse
- Somatoform pain disorder
- Symptoms magnification
- Increasing time since injury
- Disability mind set
Personality disorders or traits often affect the prognosis. People with borderline personalities may acquire pain as a method for structuring an otherwise empty existence, whereas narcissistic patients may acquire pain and seek medical attention as a way of preventing more serious illness. Those with an antisocial personality are often exploitative and prone to complications, and they may easily adopt game-playing roles. Patients with somatizing and hypochondriacal conditions are most likely to develop pain as a symptom and least likely to respond to treatments aimed at a presumed organic cause. Individuals with depression are prone to chronic pain or to have pain as a symptom. Other personality disorders or traits that may influence chronic pain include those paranoid, passive-aggressive, and avoidant conditions.
Previous learning and role models also affect the patient's prognosis and treatment outcome. An individual's cognitive or attribution style (ie, the patient's tendency to catastrophize, overgeneralize, personalize, or selectively attend to negative aspects of the pain experience) heavily influence his or her prognosis. The physical and emotional trauma that occurred during the injury or that was encountered during the ordeal of convalescence may contribute to the psychosocial milieu and create a host of emotional responses, including anxiety and fear. Psychophysiologic responses may be reinforced and include nightmares, palpitations, diaphoresis, headaches, dizziness, irritability, and fatigue. Patients are often overwhelmed and have feelings of abnormal dependence. They perceive a loss of control and look to their physician, attorney, or family for guidance. Some advisors may be oversolicitous or encourage compensation or litigation, creating further barriers to recovery.
Enduring prolonged pain also may cause emotional disturbances. Depression has already been mentioned as a common partner to chronic pain and is enhanced by loss of physical function, low self-esteem, loss of employment, and financial insecurity. Heightened anxiety may occur secondary to continued pain and the associated life disruption. Fear of injury and panic symptoms may also enhance anxiety and complicate the person's recovery. Anger or hostility directed at the workplace or perceived ineffective medical care may hinder communication with physicians, employers, family, and friends. As the length of time from injury increases, the aggregate of posttraumatic emotions becomes increasingly complex; avoidance learning and deactivation further complicate the situation.
As these barriers accumulate, the probability of a poor prognosis is enhanced. Neuropsychological factors may preexist or occur as a result of the injury. Limited cognitive dysfunction, either premorbid or from brain injury, may limit the patient's capacity to make decisions or succeed in a rehabilitation program.
Neuropsychological barriers to recovery include the following:
- Intelligence
- Brain injury
- Dementia or other organic mental syndrome
Environmental and social influences may play the strongest role in determining the patient's prognosis for recovery. Job dissatisfaction or conflict is a key predictor of chronic LBP with disability. Compensated unemployment may reinforce chronicity in these cases. Family, financial, and legal issues also affect chronicity. The patient with chronic LBP may be unable to return to a previous strenuous or heavy job and may be poorly equipped to pursue alternative vocational options because of a lack of education. Older individuals may have reduced capacity for work and less vocational potential; therefore, loss of compensation becomes an overriding issue.
Social barriers to recovery include the following:
- Job dissatisfaction or conflict
- Compensated unemployment as disincentive
- Family or spousal dynamics
- Perception of norm, ie, family history
- Legal influences
- Financial security
- Limited education or vocational potential
- Age-related factors
History, Physical Examination, and Causes
History
In most cases, chronic LBP has been investigated with appropriate physician evaluation and perhaps imaging studies. Characterization of the pain as mechanical is a primary goal when a history is obtained from a patient with chronic LBP and sciatica. Mechanical or activity-related spinal pain is most often aggravated by static loading of the spine (eg, prolonged sitting or standing), long-lever activities (eg, vacuuming or working with the arms elevated and away from the body), and levered postures (eg, forward bending of the lumbar spine). Pain is reduced when multidirectional forces balance the spine (eg, walking or constantly changing positions) and when the spine is unloaded (eg, reclining). Patients with mechanical LBP often prefer to lie still in bed, whereas those with a vascular or visceral cause are often found writhing in pain, unable to find a comfortable position.
Unrelenting pain at rest should suggest a serious cause, such as cancer or infection. Imaging studies and blood workup are usually mandatory in these cases and in cases of progressive neurologic deficit. Other historical, behavioral, and clinical signs that should alert the physician to a nonmechanical etiology requiring diagnostic evaluation are outlined below.
Diagnostic red flags
- Pain unrelieved by rest or any postural modification
- Pain unchanged despite treatment for 2-4 weeks
- Writhing pain behavior
- Colicky pain or pain associated with a visceral function
- Known or previous cancer
- Fever or immunosuppressed status
- High risk for fracture (eg, older age, osteoporosis)
- Associated malaise, fatigue, or weight loss
- Progressive neurological impairment
- Bowel or bladder dysfunction
- Severe morning stiffness as primary complaint
- Patients unable to ambulate or care for self
Nonphysiologic or implausible descriptions of pain may provide clues that operate; other psychosocial influences coexist.
Prognostic red flags
- Nonorganic signs and symptoms
- Dissociation between verbal and nonverbal pain behaviors
- Compensable cause of injury
- Out of work, disabled, or seeking disability
- Psychological features, including depression and anxiety
- Narcotic or psychoactive drug requests
- Repeated failed surgical or medical treatment for LBP or other chronic illnesses
Physical examination
Physical examination is important to confirm a mechanical or benign cause for the patient's LBP. Observations of verbal and nonverbal behaviors suggesting symptom magnification should be noted. Inspection of the spine requires the patient to disrobe. Open-back gowns give the physician only 1 view of the spine; therefore, swimming attire is often appropriate for complete, 360° inspection. Leg-length discrepancy and pelvic obliquity, scoliosis, postural dysfunction with forward head and shoulders, or accentuated kyphosis should be noted. Physicians' preferences vary in regard to the importance of testing range of motion; however, just asking the patient to bend forward often enables the most worthwhile observations.
The patient is asked to drop his or her head and shoulders forward and then move slowly into forward bending. Normal forward bending is revealed when the patient recruits from each cephalic segment to the level below, and so on, progressing from the cervical spine through the thoracic and lumbar region, where flexion of the hips completes the excursion into full flexion. Patients with clinically significant mechanical back pain or lumbar segmental instability usually stop cephalic-to-caudal segmental recruitment on reaching the thoracolumbar junction, or sometimes the involved lumbar level. To continue forward bending, they then contract their lumbar muscles to brace the mechanically compromised segment and then continue recruitment in a reverse direction, beginning with motion through the hips, then proceeding cephalad, level to level, completing the excursion of the spine to the erect posture.
In cases of severe mechanical back pain and segmental instability with regional muscular spasm, the patient often reports an inability to perform any flexion below a thoracic spinal level. Any soft-tissue abnormalities and tenderness to palpation should be recorded. Palpation of lumbar paraspinal, buttock, and other regional muscles should be performed early in the examination. The examiner should palpate and note areas with superficial and deep-muscle spasm, and he or she should identify TrPs and small, tender nodules in a muscle that elicit characteristic regional referred pain.
Dissociation of physical findings from physiologic or anatomic principles is the key in patients in whom psychological factors are suspected to be influential. Examples of this phenomenon include nondermatomal patterns of sensory loss, nonphysiologic demonstration of weakness (give-way weakness when not caused by pain, or ratchety weakness related to simultaneous agonist and antagonist muscular contraction), and dissociation between the lumbar spinal movements found during history taking or counseling sessions from movements observed during examination.
Assessment of Waddell signs have been popularized as a physical-examination technique to identify patients who have nonorganic or psychogenic embellishment of their pain syndrome. Examination techniques that Waddell proposed consist of simulated rotation of the hips en masse with the lumbar spine without allowing for spinal rotation; this maneuver normally does not cause pain. Another is the application of light pressure on the head, which should also be painless. Likewise, gentle effleurage of superficial tissues is unlikely to cause pain. Other techniques are striking dissociation between sitting and supine straight leg raising and the demonstration of nonphysiologic weakness and sensory deficits by the patient, as mentioned already.
Straight leg raising with the patient supine should produce ipsilateral leg pain between 10° and 60° to be declared positive. Straight leg raising that produces pain in the opposite leg carries a high probability of disk herniation, and investigation should be considered, especially if neurologic evidence for radiculopathy is present. Nonspecific complaints, overtly excessive pain behavior, patient contraction of antagonist muscles that limit the examiner's testing, or tightness of buttock and hamstring muscles are commonly mistaken for positive results on straight leg raising. Reverse straight leg raising may elicit symptoms of pain by inducing neural tension on irritated or compressed nerve roots in the mid-to-upper lumbar region. In addition, this maneuver helps the astute physician identify tightness of the iliopsoas muscle, which commonly contributes to chronic lumbar discomfort.
Neurologic evaluation is performed to determine the presence or absence and levels of radiculopathy or myelopathy. Anatomic localization is determined by muscle and reflex testing combined with historical information obtained during the interview and the absence of neurologic symptoms or signs that implicate cerebral or brainstem involvement. Consistent myotomal weakness and sensory findings that at least seem to coincide with segmental radiculopathy or polyradiculopathies should not be ignored.
The neurologist should identify syndromes of the lower motor neurons versus the upper motor neurons and the level of spinal dysfunction. Hyperreflexia in caudal spinal levels may change to reduced or absent reflexes in the upper extremities, determining radicular or spinal-cord localization of dysfunction. Rectal examination is indicated in patients in whom myelopathy, especially cauda equina syndrome, is a diagnostic concern. Tone of the anal sphincter; presence or absence of an anal wink; and correlation with motor, sensory, and reflex findings are appropriate in these cases.
Causes
Epidemiologic data suggest that risk factors include cigarette smoking; morbid obesity; occupations that require repetitive lifting, especially in forward bending and twisting positions, particularly when lifting requirements exceed the worker's physical capacity; and exposure to vibration caused by motor vehicles or industrial machinery. Studies indicate that smoking is most likely to be a risk factor for LBP in people with jobs that require heavy physical exertion. Fitness may be correlated with recovery and return to work after LBP; however, in prospective studies controlled for age, isometric lifting strength and degree of cardiovascular fitness were not predictive of back injury.
Occupational risk factors are difficult to define because exposures to specific causative influences are unclear, mechanisms of injury may be confusing, and supporting research findings are variable and conflicting for most environmental risks. Furthermore, job dissatisfaction, work conditions, legal and social factors, financial stressors, and emotional circumstances heavily influence back disability. Although many experts agree that heavy physical work, lifting, prolonged static work postures, simultaneous bending and twisting, and exposure to vibration may contribute to back injuries, the medical literature provides conflicting support for most of these proposed risk factors.
Extreme height and morbid obesity may predispose an individual to back pain. However, research studies have not clearly demonstrated that height, weight, or body build are directly related to the risk of back injury. Weakness of the trunk extensor muscles, compared with flexor strength, may be a risk factor for sciatica.
When LBP persists beyond 3 months, into the chronic phase, appropriate clinical and diagnostic information supporting a benign or mechanical cause should be accrued, if it has not been already. Also, prompt physician evaluation, including reasonable radiographic, laboratory, and electrophysiologic testing, is indicated in patients with persistent severe neurologic deficit, intractable limb pain, suspected systemic illness, or changes in bowel or bladder control. The spectra of mechanical (or activity-related) and nonmechanical causes of LBP are outlined below.
Mechanical or activity-related causes of LBP
- Diskal and segmental degeneration - May include facet arthropathy from osteoarthritis
- Myofascial, muscle spasm, or other soft-tissue injury and/or disorders
- Disk herniation - May include radiculopathy
- Radiographic spinal instability with possible fracture or spondylolisthesis - May be due to trauma or degeneration
- Fracture of bony vertebral body or trijoint complex - May not reveal overt radiographic instability
- Spinal canal or lateral recess stenosis
- Arachnoiditis, including postoperative scarring
Differential diagnosis can include many neurological and systemic disorders, as well as referred pain from viscera or other skeletal structures such as the hip.
Disorders that may be associated with nonmechanical LBP
- Neurologic syndromes
- Myelopathy from intrinsic or extrinsic processes
- Lumbosacral plexopathy, especially from diabetes
- Neuropathy, including inflammatory demyelinating type (ie, Guillain-Barré syndrome)
- Mononeuropathy, including causalgia
- Myopathy, including myositis and metabolic causes
- Dystonia, truncal or generalized central pain syndrome
- Systemic disorders
- Primary of metastatic neoplasm, including myeloma
- Osseous, diskal, or epidural infection
- Inflammatory spondyloarthropathy
- Metabolic bone disease, including osteoporosis
- Vascular disorders such as atherosclerosis or vasculitis
- Referred pain
- Gastrointestinal disorders
- Genitourinary disorders, including nephrolithiasis, prostatitis, and pyelonephritis
- Gynecologic disorders, including ectopic pregnancy and pelvic inflammatory disease
- Abdominal aortic aneurysm
- Hip pathology
Psychosocial factors that may influence LBP chronicity and disability
- Compensable injury
- Somatoform pain disorder
- Psychiatric syndromes, including delusional pain
- Drug seeking
- Abusive relationships
- Seeking disability or out-of-work status
Diagnostic Strategies
As indicated in the last section, unrelenting pain at rest should generate suspicion for cancer or infection. The appropriate imaging study is mandatory in these cases and in cases of progressive neurologic deficit. Plain anteroposterior and lateral lumbar spine radiographs are indicated for patients older than 50 years and for those with pain at rest, a history of serious trauma, or other potential conditions (eg, cancer, fracture, metabolic bone disease, infection, inflammatory arthropathy). The yield for discovering a serious condition with radiography outside these parameters is minimal, and the cost savings are substantial.
When LBP and sciatica persist into the subacute phase (pain lasting 6-12 wk), appropriate consultation and diagnostic imaging should be considered. Referring the patient to a physician with expertise in spinal disorders may be the most appropriate procedure for initial evaluation rather than relying on expensive diagnostic testing.
CT scanning is an effective diagnostic study when the spinal and neurologic levels are clear and bony pathology is suspected.
MRI is most useful when exact spinal and neurologic levels are unclear, when a pathologic condition of the spinal cord or soft tissues is suspected, when postoperative disk herniation is possible, or when an underlying infectious or neoplastic cause is suspected.
Myelography is useful to elucidate nerve-root pathology, particularly in patients with previous lumbar spinal surgery or with a metal fixation device in place. CT myelography provides accurate visual definition to elucidate neural compression or arachnoiditis when patients have undergone several spinal operations and when surgery is considered for the treatment of foraminal and spinal-canal stenosis.
When leg pain predominates and imaging studies provide ambiguous information, clarification may be gained by performing electromyography (EMG), somatosensory evoked potential (SSEP) testing, or selective nerve root blocks. When the cause of sciatica is related to neural compression by bony or soft-tissue structures in the spinal canal, surgical consultation should be considered. If diagnostic information is inadequate to explain the degree of neurologic deficit, pain, and disability, multidisciplinary evaluation may provide insight into perpetuating physical and psychosocial factors (see Media file 1).
Medical Care
Evidence-based clinical practice guidelines from the American Pain Society (APS) for patients with chronic low back pain describe the use of interventional diagnostic tests and therapies, surgeries, and interdisciplinary rehabilitation.4- Practice guidelines for nonradicular pain
- Interdisciplinary rehabilitation emphasizing cognitive-behavioral approaches should be considered for patients who do not respond to usual interventions.
- Provocative diskography (injecting material into a disk nucleus in an attempt to reproduce the patient's typical pain) is not recommended.
- Facet joint corticosteroid injection, prolotherapy (repeated injections of irritant material to stimulate an inflammatory response), and intradiskal corticosteroid injection are not recommended.
- Persistent disabling symptoms and degenerative spinal changes should prompt discussion and shared decision-making regarding surgery or interdisciplinary rehabilitation (evidence is insufficient to weigh the risks and benefits of vertebral disk replacement in these patients).
- Practice guidelines for persistent radiculopathy
- For patients with herniated disks, the use of epidural steroid injection should be discussed.
- For patients with herniated disks and disabling leg pain from spinal stenosis, surgical options should be discussed.
- For patients with persistent pain after surgery, the risks and benefits of spinal cord stimulation should be discussed.
The rationale for nonoperative treatment has been based on findings from clinical and autopsy studies, which demonstrate that protruding or extruded disk material can be resorbed over time.
In an uncontrolled study, Saal et al demonstrated that 90% of patients with a definite herniated lumbar disk and radiculopathy (criteria for surgical intervention), were successfully treated with aggressive rehabilitation and medical therapy.
A German neurologist, Henrik Weber, performed a longitudinal study of patients who had sciatica and confirmed disk herniations. The patients were randomly assigned to operative or nonoperative treatment. At 1-year follow-up, improvement was significantly greater in the surgically treated group than in the other. However, improvement in the groups did not significantly differ at 4-10 years of follow-up.6
Medical treatment
Treatment of spinal disorders can be divided into 3 phases based on the duration of symptoms. Primary nonoperative care consists of passively applied medical and physical therapy during the acute phase of soft-tissue healing. Secondary treatment includes spine-care education and active exercise programs that bridge the acute or the postoperative phase with return to work at previous level of function. Tertiary treatment focuses on interdisciplinary care to address LBP and disability, as well as acquired physical and psychological deconditioning that has developed as a result of chronic dysfunction.
Bed rest
Bed rest is usually appropriate for acute LBP and sciatica. Two days of bed rest is more effective than 7 days, resulting in less time lost from work. Prolonged bed rest can lead to progressive inactivity and avoidance, which reinforces abnormal illness behaviors. Such inactivity can also have deleterious physiologic effects, leading to shortened muscles and other soft tissues, joint hypomobility, reduced muscle strength, reduced cardiopulmonary endurance, and loss of mineral content from bone. For these reasons, bed rest is usually not recommended as a treatment for chronic LBP.
Medications
Principles for medical management in the chronic stages of LBP and disability differ in several ways from those in the acute phase.
Tricyclic antidepressants are useful in chronic LBP to alleviate insomnia, enhance endogenous pain suppression, reduce painful dysesthesia, and eliminate other painful disorders (eg, headaches). In addition, these medications may improve the patient's ability to cope, and they may reduce depression, anxiety, or fatigue associated with chronic LBP.
Anticonvulsant medications may reduce paroxysmal or neuropathic pain.
Calcium channel blockers and alpha-adrenergic antagonists are useful for treating LBP when it is associated with a complex regional pain syndrome.
On occasion, narcotics may be used to maintain function and mobility in a patient who has an acute exacerbation of chronic pain. However, continuous use of opioid analgesia for LBP is generally reserved as a final treatment option. When necessary, long-acting opioids should be given on a time-contingent dosing schedule rather than as needed. Improved function for achievement of vocational, recreational, and social goals are better measures of medication efficacy than subjective estimates of pain relief.
Therapeutic Spinal Interventional Techniques
Local anesthetics, corticosteroids, or other substances may be directly injected into painful soft tissues, facet joints, nerve roots, or epidural spaces. They may also be given intrathecally. Therapeutic injections have been advocated to alleviate acute pain or an exacerbation of chronic pain, to help patients remain ambulatory outpatients, to allow them to participate in a rehabilitation program, and to decrease their need for analgesics, and to avoid surgery. Local injections into paravertebral soft tissues, specifically into myofascial trigger points, are widely advocated. However, a double-blind study to compare local anesthetic with saline injections and a prospective randomized double-blind study to compare dry needling with acupressure spray applications of lidocaine, corticosteroids, and vapor coolants revealed no statistically significant difference in therapeutic effects. Other procedures use "provocate [sic] and ablate" methods to identify potential and contributing generators of spinal pain, which can then be treated with chemical or thermal neurolysis. In some cases, selective radiofrequency ablation of the lesion is performed.
Intra-articular blocks
Intra-articular injections of the facet joints are advocated by many experts as a method for diagnosis and treatment of spinal pain.7,8 Four studies of intra-articular corticosteroid injections in lumbar spine facet joints,9,10,11,12 and one study in cervical spine joints13 were performed using comparison groups that were similar demographically to the treatment group, but received another treatment. Two trials were randomized, one by Carette et al involving lumbar facet injections,9 and another by Barnsley et al involving cervical facet injections13 . Carette et al randomized 101 patients who reported more than 50% pain relief following a single intra-articular lidocaine block into a group that also received methylprednisolone. At 1-month follow-up, 42% of the methylprednisolone group and 33% of the saline group reported significant pain relief; however, at 6-month follow-up, a statistically significant comparison was identified. 46% of patients in the methylprednisolone group continued to experience pain relief compared with 15% of the patients in the saline group.
An analysis and synthesis of the evidence by Manchikanti et al excluded other referenced studies that demonstrated significant methodological flaws.7 Nonrandomized trials and observational studies have shown better results with reports of significant long-term pain relief (6 mo) ranging from 28% to 38% to 54%.
A retrospective evaluation by Lippitt showed initial relief in 50% of participants, however, only 14% of participants claimed relief at 6 months, and only 8% at 12 months.14 Lau et al, in a retrospective review, reported initial relief in 56% of the patients, 44% with continued relief at 3 months, and 35% after 6 months.15 Although some physicians advocate facet injections as a treatment method, a large prospective study16 showed no long-term benefit. Therefore, intra-articular facet injections appear to have dubious therapeutic value when used in isolation. Although opinions and success rates of facet injections vary widely, the use of intra-articular facet injections is widely supported primarily for their diagnostic use.
Medial branch blocks
Medial branch blocks have traditionally been used for both diagnostic and prognostic purposes but have demonstrated limited use as a therapeutic tool. The therapeutic role of medial branch blocks was evaluated in 3 randomized clinical trials17,10,18 and 3 nonrandomized clinical trials.19,20,21 Only one of the randomized trials used appropriate criteria to diagnose facet joint pain and showed adequate long-term follow-up of outcome data.17 Patients with chronic low back pain who failed standard nonoperative therapies were randomized into a treatment or comparison group. Both groups received blocks with anesthetic and Sarapin; however, the treatment group also received methylprednisolone as part of the injectate. All patients reported significant relief in the first 3 months, 82% between 4-6 months, and 21% between 7-12 months. Improvements were also noted in physical, functional, psychological, and return-to-work status. In the previously cited evidence-based review by the same author, median branch blocks were strongly supported for short-term pain relief and moderately supported for long-term relief of facet joint pain.7
Radiofrequency medial branch neurotomy
Percutaneous radiofrequency (RF) neurotomy of the medial branches causes temporary denaturing of the nerves to the painful facet, but this effect may wear off when axons regenerate. In a 2000 review, Manchikanti et al cite strong evidence that RF denervation provides short-term relief (<6 mo) and moderate evidence for long-term relief (>6 mo) of chronic cervical, thoracic, and lumbar spinal pain of facet origin.22 A randomized trial by Lord compared 12 patients receiving medial branch RF lesions of the cervical dorsal rami to the same number of patients receiving a sham procedure.23 Seven patients in the treatment group and one in the control group remained free of pain. Overall, patients receiving medial branch neurotomies had a long-term success rate of 75%. In another randomized trial, 47% of the treatment group showed sustained improvement following RF denervation at 12 months. Improvement measures included reduction of pain, functional disability, and physical impairment.These and other studies show strong support for both a short and long-term benefit from RF medial branch neurotomy for the treatment of lumbar facet syndrome in chronic low back pain patients.7 Potential side effects of RF denervation have included painful cutaneous dysesthesia or hyperesthesia, pneumothorax and deafferentation pain.24
Epidural injections
Epidural injections have been widely used by direct placement near the involved nerve root or by midline presentation, including caudal entry, and combining corticosteroid and local anesthetic of varying volumes. An intralaminar entry is directed more closely to the site of assumed pathology and requires less volume of the injectate than a caudal route. However, the caudal entry is usually considered a safe approach with small risk for inadvertent puncture of the dura or a neural structure. Transforaminal corticosteroid injections are more target-specific and require the least volume of injectate to reach the presumed pathoanatomic site or primary pain generator by an approach through the ventral lateral epidural space.
When considering an epidural injection, each approach has its advantages and disadvantages. The caudal approach requires a large fluid volume, thus greater dilution of the active ingredient within the injectate. Because the needle cannula is initially threaded at a relatively parallel plane to the spinal canal, the risk of intravascular, subcutaneous, subperiosteal, or interosseous needle puncture is greater.
Disadvantages of the intralaminar approach can include overdilution of the injectate, extra-epidural or intravascular placement of the needle, preferential cranial and posterior flow of the solution, and dural puncture. The intralaminar approach is also more difficult in postsurgical patients and below the L4-5 level.7 The transforaminal approach is difficult in the presence of a surgical osseous fusion or when spinal instrumentation is present. Other risks include intraneural or intravascular injection and spinal cord trauma. The use of fluoroscopy to direct needle placement and observe contrast flow should be considered requisite to reduce these potential adverse events.7,8
Evidence synthesis by Manchikanti involved review of 8 randomized or double blind trials. Five supported short-term relief25,26,27,28,29 (defined as <3 months) and 5 also supported long-term relief (defined as ³ 3 months) when a caudal injection approach was used.25,27,28,29,30 In addition, 3 prospective trials31,32,33 , and 4 retrospective trials34,35,36,37 , demonstrated support for short and long-term pain relief when epidural injections were performed in a series, rather than a single injection. An evidence synthesis for intralaminar epidural injections by Manchikanti et al showed 7 of 10 randomized trials to be positive for short-term relief, and 3 for long-term relief.7 Numerous nonrandomized trials showed patients benefiting from cervical or lumbar intralaminar epidural steroid injections.7 At present, the literature strongly supports the use of intralaminar corticosteroid epidural injections for providing short-term pain relief when treating cervical or lumbar radicular syndromes, even chronic cases; therefore, this treatment is best reserved for use as an adjunctive therapy or during a flare-up of symptoms.7 Also, transforaminal epidural injections have shown positive short- and long-term results in multiple randomized trials.7,8
Despite the literature support just cited, the debate regarding the use and benefit of epidural steroid injections for spinal pain patients still continues. Reviews by Koes et al in 1995 and 1999 supported the usefulness of lumbar and caudal epidural injections for low back pain and sciatica.38 Meta-analyses in 1995 by Watts and Silagy39 and in 1998 in by van Tulder et al40 report conflicting evidence and inconsistent findings regarding the effectiveness of epidural steroids. A 1998 review of the literature41 concluded that epidural corticosteroid injections were effective for back pain and sciatica, and, subsequently, a 2000 review by Vroomen et al cited epidural steroids as beneficial for some patients with nerve root compression and sciatica.42
In summary, the spinal interventionalist must use clinical judgment as to the rationale and safety of performing the chosen procedure in combination with clinical experience when deciding how to proceed with treatment. Therefore, in some patients, epidural injections may be considered useful as a method of pain control and may provide benefit that is adjunctive to other therapies.8
Epidural adhesiolysis
Percutaneous adhesiolysis with or without spinal endoscopy is another interventional technique used to manage chronic refractory low back pain.43,44,45,46,47,48,49,50,51,52,53,54,55,56 This procedure is performed to disrupt presumed epidural adhesions, which may affect nerves or other pain sensitive tissues. Percutaneous lysis of epidural adhesions may also enable improved delivery of injected drugs to targeted painful structures. Epidural adhesiolysis with direct deposition of corticosteroids in the spinal canal can be achieved by a 3-dimensional view using a spinal or epidural endoscope. In a synthesis of the evidence the clinical use of percutaneous epidural adhesiolysis using a spring-guided catheter with or without hypertonic saline, Manchikanti et al reported their findings with short-term relief defined as less than 3 months and long-term relief as lasting longer than 3 months. Two randomized trials55,57 were positive for both short and long-term relief. The effectiveness of spinal endoscopic adhesiolysis was summarized by an evidence synthesis by Manchikanti et al7 with review and comparison of 2 prospective58,59 and 4 retrospective studies43,55,56,57 . The effectiveness of spinal endoscopic adhesiolysis was further evaluated by reviewing 2 prospective58,59 and 2 retrospective studies43,60 . Short-term relief was defined as less than 6 months and long-term relief as more than 6 months. All studies showed support for short-term improvement, but none demonstrated any evidence to support long-term benefit.
Complications of adhesiolysis with spinal endoscopy may include dural puncture, spinal cord compression, catheter sheering, infection, injury from the endoscope, and administration of high volumes of fluid. Epidural infusion of high volumes of fluid, especially hypertonic saline, can potentially cause excessive epidural hydrostatic pressure, resulting in spinal cord compression, elevated interspinal or intracranial pressure, epidural hematoma, bleeding, increased intraocular pressures with resultant visual deficiencies including blindness, and dural rupture.7 Unintended subarachnoid or subdural puncture with injection of local anesthetic or hypertonic saline can also occur with resultant neural catastrophe.7 Hypertonic saline injection into the subarachnoid space has been reported to cause cardiac arrhythmia, myelopathy, and loss of sphincter control.7,61 Arachnoiditis and sheering of the catheter with retention has also been reported with epidural adhesiolysis and hypertonicsaline.62,63,64 In summary, these procedures should only be performed under fluoroscopic control by well-trained, experienced spinal interventionalists.
Intradiskal therapies
A variety of intradiskal procedures have been developed because disk is often presumed causative for many painful spinal and radicular syndromes. A prospective randomized double-blind study of interdiskal injections into diskography-confirmed painful disks showed no statistically significant benefit between corticosteroids and local anesthetics.65 Other therapies include chymopapain injections to achieve nucleolysis, percutaneous manual nucleotomy with nucleotome, thermal vaporization with laser, and percutaneous decompression with nucleotomy using Coblation technology (nucleoplasty). Intradiskal electrothermal therapy (IDET) is a minimally invasive technique in which the annulus is subjected to thermomodulation.7
The use of diagnostic diskography has been combined with therapeutic percutaneous intradiskal procedures in patients who demonstrate a concordant pain response. These include IDET, percutaneous laser disk decompression (PLDD), percutaneous radiofrequency annular neurolysis, and nucleoplasty.66 These procedures are postulated to shrink collagen fibers and coagulate neural tissues, thereby alleviating nociception produced by mechanical loading upon a painful disk.
IDET is performed using radiographic placement of a 17-gauge introducer needle through a posterior annular wall into the nucleus of symptomatic disks as determined by diskography. A navigable catheter with a temperature-control, thermal-resistant coil is passed through the needle so that it curls along the posterior inner annulus. Catheter temperatures are slowly raised to 90°C, causing thermocoagulation of intradiskal and inner annular collagen, as well as associated nociceptors. Reduction in pain symptoms may result from denervation or shrinking and remodeling of the diskal structure, or both.66
Karasek and Bogduk introduced a flexible electrode into a "discography symptomatic disc" with internal disk disruption.67 The electrode was passed circumferentially along the inner annulus to heat and coagulate annular collagen and nociceptive nerve fibers. Of the 35 treated patients, 23% achieved complete pain relief and 60% improved. Improvements were sustained at 6 and 12 months. Seventeen patients comprising a parallel comparison group did not benefit from a physical rehabilitation program alone, except 1 patient who had dramatic pain reduction.67 At a 2-year follow-up, 54% of the patients had achieved at least 50% relief with concomitant functional improvement.68 A randomized double-blind study by Pauza et al was presented in 2002 and published in a review by Wetzel et al.69,70 In fact, multiple prospective and retrospective studies examining the efficacy of this procedure have been published.67,68,69,71,72,73,74,75,70
A study by Saal and Saal of 62 patients showed improvement in multiple parameters of greater than 70% of cases at 12 months or longer.76 Wetzel reported that all studies shared common designs using prospective cohorts with historical or noninterventional groups as controls.69 Wetzel et al concluded that pain due to lumbar disk disease may be diminished by IDET with all studies suggesting an overall positive effect.69 Manchikanti et al, in his comprehensive 2003 review to determine evidence-based practice guidelines for interventional techniques, reports that IDET shows moderate evidence to support short-term relief, but limited evidence to support long-term relief.7 Complications from IDET have included catheter breakage and cauda equina syndrome.7
Physical Therapy, Surgery, and Other Care
Physical therapy
Physical therapy for the spine can be divided into passive and active therapies. Passive therapies are those that physiotherapists apply, including modalities such as ultrasound, electric muscle stimulation, traction, heat and ice, and manual therapy. Passive modalities are most appropriate when used for short-term treatment of an acute back injury or an exacerbation of chronic LBP. When possible, self-administration of appropriate modalities by the patient is frequently advocated, especially for those with chronic LBP.
Corsets and braces are long-used adjuncts to treatment, though their efficacy has not been demonstrated in methodologically sound studies. As many as 89% of patients who use a brace have reported benefit from this therapy. The primary mechanisms of action are unclear and probably differ by the type of brace and the patient's morphology, pathoanatomy, and spinal activities. Also, a rigid orthosis is more effective than a simple support aid.
Traction is a long-endured medical prescription for LBP and applied in a variety of methods to treat conditions of the spine. Acute pain or an exacerbation of chronic LBP is the usual recommended indication. When traction is administered to the lumbar spine, at least 60% of the patient's body weight is necessary to produce dimensional changes in the lumbar disk. However, no evidence suggests that this maneuver reduces disk herniation.
Another treatment with a long history of utility for the treatment of LBP is spinal manipulation, which analytically appears to be most beneficial for the treatment of acute axial spine pain without radiculopathy or neurologic impairment.
Exercise is widely used to treat LBP, but again, research findings without methodologic flaws to support this therapeutic approach are limited. Dynamic stabilization exercises are widely accepted as being effective. This technique begins with the spine placed in a neutral position, which is defined as the posture of least pain, biomechanical stress, and potential risk for injury. The patient is taught to maintain this position while the surrounding muscles isometrically brace the spine. The extremities can then be moved in patient positions ranging from supine to standing by using no resistance other than the weight of the arms and legs or by adding free weights, weight machines, or functional activities.
Sertpoyraz et al compared isokinetic and standard exercise programs for chronic low back pain. Pain, mobility, disability, psychological status, and muscle strength were measured. Forty patients were randomly assigned to a program that took place in an outpatient rehabilitation clinic. Results showed an equal effect in the treatment of low back pain, with no statistically significant difference found between the 2 programs.77
Although back schools to educate and train patients have been popular internationally, they have been ineffective as preventive measures. However, back schools have had 94-96% rates for patient satisfaction. In a prospective RCT to compare exercise alone with back-school education plus exercise, the back-school group had significant improvements in pain and disability. Furthermore, at 16 weeks, the exercise-only group had reverted to their original level of disability, whereas the back-school group had continued improvement. Other studies have shown that patients with LBP who participate in back schools return to work earlier, that they seek less follow-up medical attention, and that they have less frequent episodes of pain than other patients.
Functional restoration
Mayer and others devised FR to address the deconditioning syndrome, a requisite companion to LBP disability. FR is best described as a sports-medicine approach to address industrial back injuries with a program of physical training to restore normal flexibility, strength, and endurance. Advocated FR programs are highly structured and interdisciplinary and consist of daily intensive physical, psychological, and behavioral reconditioning. Patients participate in progressively increasing levels of task-oriented rehabilitation and work simulation and undergo objective measurements of their physical and functional improvement.
Most programs couple this physical training with cognitive-behavioral support, which includes didactic sessions regarding the nature of the pain, spinal care, pain management, and disability avoidance. Programs usually conclude with an exit evaluation that provides the individual with measures of his or her physical and functional capacity, as well as guidelines for postures, activities to avoid, and weight limits on material handling. These items are measured so that parameters that are correlated with the consistency of effort can be determined. These physical and functional parameters can be used to establish return-to-work guidelines.
In 1987, Mayer et al reported results of a 2-year prospective study of FR to treat industrial low-back injuries. Although patients were not truly randomly assigned to treatment or comparison groups and though they did not represent the general population, 87% of the treated group who could be contacted were working 1 year after completing the program. At 1 year, only 41% of the comparison group (composed of patients who could not obtain insurance approval to enter the program) and 25% of those who dropped out of the program were working.
Mayer et al also demonstrated a reduced need for additional surgical and medical care in the treatment group compared with the other groups.
An FR program similar to the one above demonstrated similar results. However, other similar programs have not replicated the same degree of success. An FR study involving 11 treatment centers in 7 states, which emphasized work hardening and which excluded structured psychosocial programs, showed statistically increased return-to-work rates with FR versus a comparison group at 6-month (66%) and 12-month (77%) follow-up (P < .0001). Furthermore, postsurgical patients had a return-to-work rate similar to that of nonsurgical patients.
FR treatment for spine-related pain, especially chronic LBP and disability, appears appropriate for selected patients. However, predicting which patients will respond favorably is not yet possible. Although data suggest these intensive programs may save money; treatment is still costly by most standards.
Care by pain clinics
Behavioral and cognitive behavioral, inpatient and outpatient multidisciplinary pain clinics usually are considered to be the last resort as a treatment option. This course of treatment usually is offered late in the course of chronic LBP, typically after the patient has adopted a disability lifestyle automated by refractory operant influences. True behavioral modification is most effectively accomplished in an inpatient setting, where all aspects of the patient's waking and sleeping activities can be structured and controlled. The cost of hospitalization and interdisciplinary services in this venue must be weighed against other economic factors, such as those related to further medical or surgical care, loss of productivity, and compensated disability.
Cognitive-behavioral pain treatment programs are usually combined with an FR approach and prove to be a successful treatment for many. Validation of pain treatment centers is usually based on presumed future cost savings.
Surgery
Surgery for chronic LBP is highly controversial and offers unpredictable results. Spinal fusion provides some benefit for carefully selected patients with diskogenic LBP. Patients with chronic LBP and concordant pain, as demonstrated on lumbar diskography, and who have no significant psychological disturbances, compensable illness, or litigiousness may be potential surgical candidates. However, current indications for surgical treatment of chronic LBP are not widely accepted.
For providers of nonoperative spinal care, certain clinical circumstances should prompt consultation with a spine surgeon. Indications for such consultation include impact trauma causing fracture or spinal malalignment (eg, subluxation), bowel or bladder dysfunction (eg, cauda equina syndrome), or progressive deterioration of neurological status. When tumor or spinal infection is suspected, spine surgery consultation should be considered in an expedient manner. Structural abnormalities, such as spinal stenosis or spondylolisthesis, even when symptomatic, can be evaluated within 1-3 weeks. Patients with progressive sciatica should also be referred within 6-12 weeks after onset to give the patient the best opportunity to recover any correctable neurologic impairment with surgical therapy.
Prevention
Morbid obesity and smoking are epidemiologically correlated with LBP and may affect the pathogenesis of this disorder. Fitness may be correlated with recovery and return to work after LBP. However, in prospective studies controlled for age, isometric lifting strength and degree of cardiovascular fitness were not predictive of back injury. Because job dissatisfaction may have the greatest effect on low back disability, preinjury interventions by employers may be the most powerful preventive measures.
Chronic LBP develops in a complex milieu of interwoven physiologic, psychological, and social factors that create a disease state unique to each individual. Knowledge and identification of these factors enable the treatment team to enact a comprehensive approach with the best likelihood for success. The range of treatment varies from low-technology sympathy to high-technology augmentative neurosurgery; the range of success or failure is equally broad.
Patient education
For excellent patient education resources, visit eMedicine's Bone Health Center and Back, Ribs, Neck, and Head Center. Also, see eMedicine's patient education articles Back Pain, Chronic Pain, Sciatica, and Pain Medications.
Multimedia
![]() | Media file 1: Algorithm for the management of low back pain and sciatica. |
Keywords
back pain, chronic back pain, lower back pain, LBP, chronic low back pain, cLBP, chronic lumbar pain, lumbar pain, lumbar spine pain, degeneration of the spine, spinal degeneration, back trauma, spine trauma, trauma of the spine, spinal trauma, chronic lumbago, chronic lumbar muscle spasm, lumbar disc degeneration and spondylosis, lumbar segmental degeneration and instability with concomitant soft tissue dysfunction, myofascial pain syndrome, fibrositis, inflammatory spondyloarthropathy, metabolic bone disease
More on Pathophysiology of Chronic Back Pain |
| References |
References
Kuslich SD, Ulstrom CL, Michael CJ. The tissue origin of low back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Orthop Clin North Am. Apr 1991;22(2):181-7. [Medline].
Mooney V. Presidential address. International Society for the Study of the Lumbar Spine. Dallas, 1986. Where is the pain coming from?. Spine. Oct 1987;12(8):754-9. [Medline].
Wall PD, Gutnick M. Ongoing activity in peripheral nerves: the physiology and pharmacology of impulses originating from a neuroma. Exp Neurol. Jun 1974;43(3):580-93. [Medline].
[Guideline] Chou R, Loeser JD, Owens DK, Rosenquist RW, Atlas SJ, Baisden J, et al. Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain Society. Spine. May 1 2009;34(10):1066-77. [Medline].
[Best Evidence] Chou R, Atlas SJ, Stanos SP, Rosenquist RW. Nonsurgical interventional therapies for low back pain: a review of the evidence for an american pain society clinical practice guideline. Spine. May 1 2009;34(10):1078-93. [Medline].
Weber H. Lumbar disc herniation. A controlled, prospective study with ten years of observation. Spine. Mar 1983;8(2):131-40. [Medline].
Manchikanti L, Staats PS, Singh V, Schultz DM, Vilims BD, Jasper JF, et al. Evidence-based practice guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician. Jan 2003;6(1):3-81. [Medline].
Wheeler Ah, Murrey DB. Spinal pain: pathogenesis, evolutionary mechanisms and management. In: Pappagallo M, ed. The Neurological Basis of Pain. 421-52. New York: McGraw-Hill; 2003.
Carette S, Marcoux S, Truchon R, Grondin C, Gagnon J, Allard Y, et al. A controlled trial of corticosteroid injections into facet joints for chronic low back pain. N Engl J Med. Oct 3 1991;325(14):1002-7. [Medline].
Marks RC, Houston T, Thulbourne T. Facet joint injection and facet nerve block: a randomised comparison in 86 patients with chronic low back pain. Pain. Jun 1992;49(3):325-8. [Medline].
Nash TP. Facet joints. Intra-articular steroids or nerve blocks?. Pain Clinic. 77-82;3:1990.
Lilius G, Laasonen EM, Myllynen P, Harilainen A, Gronlund G. Lumbar facet joint syndrome. A randomised clinical trial. J Bone Joint Surg Br. Aug 1989;71(4):681-4. [Medline].
Barnsley L, Lord SM, Wallis BJ, Bogduk N. Lack of effect of intraarticular corticosteroids for chronic pain in the cervical zygapophyseal joints. N Engl J Med. Apr 14 1994;330(15):1047-50. [Medline].
Lippitt AB. The facet joint and its role in spine pain. Management with facet joint injections. Spine. Oct 1984;9(7):746-50. [Medline].
Lau LS, Littlejohn GO, Miller MH. Clinical evaluation of intra-articular injections for lumbar facet joint pain. Med J Aust. Dec 9-23 1985;143(12-13):563-5. [Medline].
Jackson RP, Jacobs RR, Montesano PX. 1988 Volvo award in clinical sciences. Facet joint injection in low-back pain. A prospective statistical study. Spine. Sep 1988;13(9):966-71. [Medline].
Manchikanti L, Pampati V, Bakhit CE, Rivera JJ, Beyer CD, Damron KS, et al. Effectiveness of lumbar facet joint nerve blocks in chronic low back pain: a randomized clinical trial. Pain Physician. Jan 2001;4(1):101-17. [Medline].
Nash TP. Facet joints. Intra-articular steroids or nerve blocks?. Pain Clinic. 3:77-82.
Barnsley L, Bogduk N. Medial branch blocks are specific for the diagnosis of cervical zygapophyseal joint pain. Reg Anesth. Nov-Dec 1993;18(6):343-50. [Medline].
Manchikanti L, Pampati V, Fellows B, Bakhit CE. The diagnostic validity and therapeutic value of lumbar facet joint nerve blocks with or without adjuvant agents. Curr Rev Pain. 2000;4(5):337-44. [Medline].
North RB, Han M, Zahurak M, Kidd DH. Radiofrequency lumbar facet denervation: analysis of prognostic factors. Pain. Apr 1994;57(1):77-83. [Medline].
Manchikanti L, Singh V, Vilims BD, Hansen HC, Schultz DM, Kloth DS. Medial branch neurotomy in management of chronic spinal pain: systematic review of the evidence. Pain Physician. Oct 2002;5(4):405-18. [Medline].
Lord SM, Barnsley L, Bogduk N. Percutaneous radiofrequency neurotomy in the treatment of cervical zygapophysial joint pain: a caution. Neurosurgery. Apr 1995;36(4):732-9. [Medline].
Hammer M,. Meneese W: Principles and practice of radiofrequency neurolysis. Cur Rev Pain. 1998;2:267-78.
Breivik H, Hesla PE, Molnar I, et al. Treatment of chronic low back pain and sciatica. Comparison of caudal epidural injections of bupivacaine and methylprednisolone with bupivacaine followed by saline. In: Bonica JJ, Albe-Fessard D, eds. Advances in pain research and therapy. Vol 1. New York: Raven Press; 1976:927-32.
Bush K, Hillier S. A controlled study of caudal epidural injections of triamcinolone plus procaine for the management of intractable sciatica. Spine. 16(5):572-5. [Medline].
Manchikanti L, Pampati V, Rivera JJ, Beyer C, Damron KS, Barnhill RC. Caudal epidural injections with sarapin or steroids in chronic low back pain. Pain Physician. Oct 2001;4(4):322-35. [Medline].
Helsa PE, Breivik H:. Epidural analgesia and epidural steroid injection for treatment of chronic low back pain and sciatica. Tidsskr Nor Laegeforen. 1979;99:936-9.
Revel M, Auleley GR, Alaoui S, Nguyen M, Duruoz T, Eck-Michaud S, et al. Forceful epidural injections for the treatment of lumbosciatic pain with post-operative lumbar spinal fibrosis. Rev Rhum Engl Ed. Apr 1996;63(4):270-7. [Medline].
Mathews JA, Mills SB, Jenkins VM, Grimes SM, Morkel MJ, Mathews W, et al. Back pain and sciatica: controlled trials of manipulation, traction, sclerosant and epidural injections. Br J Rheumatol. Dec 1987;26(6):416-23. [Medline].
Manchikanti L, Singh V, Rivera JJ, Pampati V, Beyer C, Damron K. Effectiveness of caudal epidural injections in discogram positive and negative chronic low back pain. Pain Physician. Jan 2002;5(1):18-29. [Medline].
Yates DW. A comparison of the types of epidural injection commonly used in the treatment of low back pain and sciatica. Rheumatol Rehabil. Aug 1978;17(3):181-6. [Medline].
Waldman SD. The caudal epidural administration of steroids in combination with local anesthetics in the palliation of pain secondary to radiographically documented lumbar herniated disc: A prospective outcome study with 6-months follow-up. Pain Clinic. 1998;11:43-9.
Hauswirth R, Michot F:. Caudal epidural injection in the treatment of low back pain. Ischweizerische Medizinische Wochenschrift. 1982;112:222-5.
Manchikanti L, Pakanati RR, Pampati V. Comparison of three routes of epidural steroid injections in low back pain. Pain Digest. 1999;9:277-85.
Goebert HW, Jallo SJ, Gardner WJ, Wasmuth CE. Painful radiculopathy treated with epidural injections of procaine and hydrocortisone acetate: results in 113 patients. Anesth Analg. Jan-Feb 1961;40:130-4. [Medline].
Clocon JO, Galindo-Clocon D, Amarnath L, et al. Caudal epidural blocks for elderly patients with lumbar canal stenosis. J Am Geriatr Soc. 1994;42:593-6.
Koes BW, Scholten RJ, Mens JM, Bouter LM. Efficacy of epidural steroid injections for low-back pain and sciatica: a systematic review of randomized clinical trials. Pain. Dec 1995;63(3):279-88. [Medline].
Watts RW, Silagy CA. A meta-analysis on the efficacy of epidural corticosteroids in the treatment of sciatica. Anaesth Intensive Care. Oct 1995;23(5):564-9. [Medline].
van Tulder MWV, Koes BW, Bouter LM. Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions. Spine. 1997;22:2128-56.
McQuay HJ, Moore RA. Epidural corticosteroids for sciatica. In: An Evidence-Based Resource for Pain Relief. New York: Oxford University Press; 1998:216-8.
Vroomen PC, de Krom MC, Slofstra PD, Knottnerus JA. Conservative treatment of sciatica: a systematic review. J Spinal Disord. Dec 2000;13(6):463-9. [Medline].
Racz GB, Holubec JT. Lysis of adhesions in the epidural space. In: Racz GB, ed. Techniques of Neurolysis. Boston: Kluwer Academic Press; 57-72.
Manchikanti L, Singh V. Epidural lysis of adhesions and myeloscopy. Curr Pain Headache Rep. Dec 2002;6(6):427-35. [Medline].
Anderson SR, Racz GB, Heavner J. Evolution of epidural lysis of adhesions. Pain Physician. Jul 2000;3(3):262-70. [Medline].
Racz GB, Sabonghy M, Gintautas J, Kline WM. Intractable pain therapy using a new epidural catheter. JAMA. Aug 6 1982;248(5):579-81. [Medline].
Manchikanti L, Saini B, Singh V. Lumbar epidural adhesiolysis. In: Manchikanti L, Slipman CW, Fellows B, eds. Interventional Pain Management: Low Back Pain – Diagnosis and Treatment. Paducah, KY: ASIPP Publishing; 2002:353-90.
Manchikanti L, Singh V. Lumbar endoscopic adhesiolysis. In: Manchikanti L, Slipman CW, Fellows B, eds. Interventional Pain Management: Low Back Pain – Diagnosis and Treatment. Paducah, KY: ASIPP Publishing; 2002:391-410.
Manchikanti L, Saini B, Singh V. Spinal endoscopy and lysis of epidural adhesions in the management of chronic low back pain. Pain Physician. Jul 2001;4(3):240-65. [Medline].
Lewandowski EM. The efficacy of solutions used in caudal neuroplasty. Pain Digest. 1997;7:323-30.
Saberski LR, Kitahata LM. Direct visualization of the lumbosacral epidural space through the sacral hiatus. Anesth Analg. Apr 1995;80(4):839-40. [Medline].
Heavner JE, Chokhavatia S, Kizelshteyn G:. Percutaneous evaluation of the epidural and subarachnoid space with the flexible fiberscope. Reg Anesth. 1991;15S1:85.
Saberski KR, Kitahata L:. Review of the clinical basis and protocol for epidural endoscopy. Connecticut Med. 1995;50:71-3.
Saberski LR, Brull S. Fiberoptic visualization of the spinal cord. A histroical review and report of current methods. Yale Biol Med. 1995;68:7-16.
Manchikanti L, Pampati V, Fellows B, Rivera J, Beyer CD, Damron KS. Role of one day epidural adhesiolysis in management of chronic low back pain: a randomized clinical trial. Pain Physician. Apr 2001;4(2):153-66. [Medline].
Manchikanti L, Pakanati R, Bakhit CE, et al.:. Role of adhesiolysis and hypertonic saline neurolysis in management of low back pain. Evaluation of modification of Racz protocol. Pain Digest. 1999;9:91-6.
Manchikanti L, Pampati V, Bakhit CE, Pakanati RR. Non-endoscopic and endoscopic adhesiolysis in post-lumbar laminectomy syndrome: a one-year outcome study and cost effectiveness analysis. Pain Physician. Oct 1999;2(3):52-8. [Medline].
Geurts JW, Kaliewaard JW, Richardson J, et al. Targeted methylprednisoione acetate/hyaluronidase/clonidine injection after diagnostic epiduroscopy for chronic sciatica: A prospective, 3-year follow-up study. Reg Anesth Pain Med. 2002;27:343-52. [Medline].
Richardson J, McGurgan P, Cheema S, Prasad R, Gupta S. Spinal endoscopy in chronic low back pain with radiculopathy. A prospective case series. Anaesthesia. May 2001;56(5):454-60. [Medline].
Manchikanti L:. The value and safety of epidural endoscopic adhesiolysis. Amer J Anesthesiol. 2000;275-278.
Kim RC, Porter RW, Choi BH, Kim SW. Myelopathy after the intrathecal administration of hypertonic saline. Neurosurgery. May 1988;22(5):942-5. [Medline].
Aldrete JA, Zapata JC, Ghaly R. Arachnoiditis following epidural adhesiolysis with hypertonic saline report of two cases. Pain Digest. 1996;6:368-70.
Lou L, Racz G, Heavner J. Percutaneous epidural neuroplasty. In: Waldman SD. Interventional Pain Management. 2nd ed. Philadelphia: WB Saunders; 2000:434-45.
Manchikanti L, Bakhit CE. Removal of a torn Racz catheter from lumbar epidural space. Reg Anesth. Nov-Dec 1997;22(6):579-81. [Medline].
Simmons JW, McMillin JN, Emery SF, Kimmich SJ. Intradiscal steroids. A prospective double-blind clinical trial. Spine. Jun 1992;17(6 Suppl):S172-5. [Medline].
Pinzon EG:. Treating lumbar back pain. Practical. Pain Manag,. April/May: 2001.;14-20,.
Karasek M, Bogduk N. Twelve-month follow-up of a controlled trial of intradiscal thermal anuloplasty for back pain due to internal disc disruption. Spine. Oct 15 2000;25(20):2601-7. [Medline].
Bogduk N, Karasek M. Two-year follow-up of a controlled trial of intradiscal electrothermal anuloplasty for chronic low back pain resulting from internal disc disruption. Spine J. Sep-Oct 2002;2(5):343-50. [Medline].
Wetzel FT, McNally TA, Phillips FM. Intradiscal electrothermal therapy used to manage chronic discogenic low back pain: new directions and interventions. Spine. Nov 15 2002;27(22):2621-6. [Medline].
Pauza K, Howell S, Dreyfuss P, et al. A randomized, double-blink placebo controlled trial evaluating the efficacy of intradiscal electothermal anuloplasty (IDET) for the treatment of chronic discogenic low back pain: 6 month outcomes. Proc Int Spinal Injection Soc. Sept 7 2002.
Saal JA, Saal JS. Nonoperative treatment of herniated lumbar intervertebral disc with radiculopathy. An outcome study. Spine. Apr 1989;14(4):431-7. [Medline].
Derby R, Eek B, Chen Y, et al. Intradiscal electrothermal anuloplasty (IDET): A novel approach for treating chronic discogenic back pain. Neuromodulation. 2000;3:82-88.
Singh V. Intradiscal electrothermal therapy: a preliminary report. Pain Physician. Oct 2000;3(4):367-73. [Medline].
Endres SM, Fiedler GA, Larson KL. Effectiveness of intradiscal electrothermal therapy in increasing function and reducing chronic low back pain in selected patients. WMJ. 2002;101(1):31-4. [Medline].
Gerszten PC, Welch WC, McGrath PM, Willis SL. A Prospective Outcomes Study Of Patients Undergoing Intradiscal Electrothermy (IDET) For Chronic Low Back Pain. Pain Physician. Oct 2002;5(4):360-4. [Medline].
Saal JA, Saal JS. Intradiscal electrothermal treatment for chronic discogenic low back pain: a prospective outcome study with minimum 1-year follow-up. Spine. Oct 15 2000;25(20):2622-7. [Medline].
[Best Evidence] Sertpoyraz F, Eyigor S, Karapolat H, Capaci K, Kirazli Y. Comparison of isokinetic exercise versus standard exercise training in patients with chronic low back pain: a randomized controlled study. Clin Rehabil. Mar 2009;23(3):238-47. [Medline].
Ahlgren SA, Hansen T. The use of lumbosacral corsets prescribed for low back pain. Prosthet Orthot Int. Aug 1978;2(2):101-4. [Medline].
Anderssen GBJ. The epidemiology of spinal disorders. In: Frymoyer JW, ed. The Adult Spine: Principles and Practice. New York, NY: Raven Press;1997:93-141.
Aprill C, Dwyer A, Bogduk N. Cervical zygapophyseal joint pain patterns. II: A clinical evaluation. Spine. Jun 1990;15(6):458-61. [Medline].
Argoff C, Nicholson B, Moskowitz M, et al. Effectiveness of lidocaine patch 5% (Lidoderm) in the treatment of low back pain (LBP). In: Program and Abstracts of the IASP 10th World Congress on Pain. August 17-22, 2002; San Diego, Calif. [Abstract] 176:172.
Argoff CA, Wheeler AH. Spinal and radicular pain disorders. Neurol Clin. Nov 1998;16(4):833-50. [Medline].
Ashton IK, Ashton BA, Gibson SJ, et al. Morphological basis for back pain: the demonstration of nerve fibers and neuropeptides in the lumbar facet joint capsule but not in ligamentum flavum. J Orthop Res. Jan 1992;10(1):72-8. [Medline].
Auld AW, Maki-Jokela A, Murdoch DM. Intraspinal narcotic analgesia in the treatment of chronic pain. Spine. Oct 1985;10(8):777-81. [Medline].
Axelsson P, Johnsson R, Stromqvist B. Effect of lumbar orthosis on intervertebral mobility. A roentgen stereophotogrammetric analysis. Spine. Jun 1992;17(6):678-81. [Medline].
Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. Dec 2 1998;280(21):1831-6. [Medline].
Barrera P, Blom A, van Lent PL, et al. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum. Sep 2000;43(9):1951-9. [Medline].
Bats-Baril WL, Frymoyer JW. The economics of spinal disorders. In: Frymoyer JW, ed. The Adult Spine: Principles and Practice. New York, NY: Raven Press;1991:85-105.
Battie MC, Bigos SJ, Fisher LD, et al. A prospective study of the role of cardiovascular risk factors and fitness in industrial back pain complaints. Spine. Feb 1989;14(2):141-7. [Medline].
Battie MC, Bigos SJ, Fisher LD, et al. Isometric lifting strength as a predictor of industrial back pain reports. Spine. Aug 1989;14(8):851-6. [Medline].
Battie MC, Videman T, Gill K, et al. 1991 Volvo Award in clinical sciences. Smoking and lumbar intervertebral disc degeneration: an MRI study of identical twins. Spine. Sep 1991;16(9):1015-21. [Medline].
Bennett RM. Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc. Apr 1999;74(4):385-98. [Medline].
Bergquist-Ullman M, Larsson U. Acute low back pain in industry. A controlled prospective study with special reference to therapy and confounding factors. Acta Orthop Scand. 1977;(170):1-117. [Medline].
Berry H, Hutchinson DR. A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain. J Int Med Res. Mar-Apr 1988;16(2):75-82. [Medline].
Berry H, Hutchinson DR. Tizanidine and ibuprofen in acute low-back pain: results of a double-blind multicentre study in general practice. J Int Med Res. Mar-Apr 1988;16(2):83-91. [Medline].
Biering-Sorensen F. Low back trouble in a general population of 30-, 40-, 50-, and 60-year-old men and women. Study design, representativeness and basic results. Dan Med Bull. Oct 1982;29(6):289-99. [Medline].
Biering-Sorensen F. Physical measurements as risk indicators for low-back trouble over a one-year period. Spine. Mar 1984;9(2):106-19. [Medline].
Bigos SJ, Battie MC, Spengler DM, et al. A prospective study of work perceptions and psychosocial factors affecting the report of back injury [published erratum appears in Spine 1991 Jun;16(6):688]. Spine. Jan 1991;16(1):1-6. [Medline].
Blazer DG. Narcissism and the development of chronic pain. Int J Psychiatry Med. 1980-81;10(1):69-77. [Medline].
Blumer D, Heilbronn M. Chronic pain as a variant of depressive disease: the pain-prone disorder. J Nerv Ment Dis. Jul 1982;170(7):381-406. [Medline].
Bogduk N. The zygapophyseal joints. In: Clinical Anatomy of the Lumbar Spine and Sacrum. 3rd ed. New York, NY: Churchill Livingstone; 1997:34-41.
Bonabello A, Galmozzi MR, Bruzzese T, Zara GP. Analgesic effect of bisphosphonates in mice. Pain. Apr 2001;91(3):269-75. [Medline].
Bonica JJ. General considerations of chronic pain. The Management of Pain. In: Bonica JJ, ed. 2nd ed. Philadelphia, Pa: Lea & Febiger;1990:180-6.
Bonica JJ. Multidisciplinary/Interdisciplinary pain program. In: Bonica JJ, ed. The Management of Pain. 2nd ed. Philadelphia, Pa: Lea & Febiger; 1990:197-202.
Boshuizen HC, Verbeek JH, Broersen JP, Weel AN. Do smokers get more back pain?. Spine. Jan 1993;18(1):35-40. [Medline].
Browning R, Jackson JL, O''Malley PG. Cyclobenzaprine and back pain: a meta-analysis. Arch Intern Med. Jul 9 2001;161(13):1613-20. [Medline].
Burke SA, Harms-Constas CK, Aden PS. Return to work/work retention outcomes of a functional restoration program. A multi-center, prospective study with a comparison group. Spine. Sep 1 1994;19(17):1880-5. [Medline].
Carette S, Marcoux S, Truchon R, et al. A controlled trial of corticosteroid injections into facet joints for chronic low back pain. N Engl J Med. Oct 3 1991;325(14):1002-7. [Medline].
Carlton SM, Zhou S, Coggeshall RE. Evidence for the interaction of glutamate and NK1 receptors in the periphery. Brain Res. Apr 20 1998;790(1-2):160-9. [Medline].
Cavanaugh JM, Weinstein JN. Low back pain: epidemiology, anatomy and neurophysiology. In: Wall PD, Melzack R, eds. Textbook of Pain. 3rd ed. London: Churchill Livingstone; 1994:441-55.
Chaffin DB, Herrin GD, Keyserling WM. Preemployment strength testing: an updated position. J Occup Med. Jun 1978;20(6):403-8. [Medline].
Cherkin DC, Deyo RA, Loeser JD, et al. An international comparison of back surgery rates. Spine. Jun 1 1994;19(11):1201-6. [Medline].
Chevlen E. Morphine with dextromethorphan: conversion from other opioid analgesics. J Pain Symptom Manage. Jan 2000;19(1 Suppl):S42-9. [Medline].
Cochran J. Efficacy of zonisamide in the treatment of neuropathic pain. Paper presented at: 21st Annual Scientific Meeting of the American Pain Society. 2002.
Cuckler JM, Bernini PA, Wiesel SW, et al. The use of epidural steroids in the treatment of lumbar radicular pain. A prospective, randomized, double-blind study. J Bone Joint Surg Am. Jan 1985;67(1):63-6. [Medline].
Cui JG, Holmin S, Mathiesen T, et al. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain. Dec 1 2000;88(3):239-48. [Medline].
Cunningham LS, Kelsey JL. Epidemiology of musculoskeletal impairments and associated disability. Am J Public Health. Jun 1984;74(6):574-9. [Medline].
Damkot DK, Pope MH, Lord J, Frymoyer JW. The relationship between work history, work environment and low-back pain in men. Spine. May-Jun 1984;9(4):395-9. [Medline].
Deleo JA, Colburn RW. The role of cytokines in nociception and chronic pain. In: Weinstein JN, Gordan SL, eds. Low Back Pain: A Scientific and Clinical Overview. Rosemount, Ill: American Academy of Orthopedic Surgeons; 1996:163-85.
Destouet JM, Gilula LA, Murphy WA, Monsees B. Lumbar facet joint injection: indication, technique, clinical correlation, and preliminary results. Radiology. Nov 1982;145(2):321-5. [Medline].
Devulder J, De Laat M. Lamotrigine in the treatment of chronic refractory neuropathic pain. J Pain Symptom Manage. May 2000;19(5):398-403. [Medline].
Deyo RA. Back pain revisited: newer thinking on diagnosis and therapy. Consultant. 1993;33:88-100.
Deyo RA. Drug therapy for back pain. Which drugs help which patients?. Spine. Dec 15 1996;21(24):2840-9; discussion 2849-50. [Medline].
Deyo RA. Nonoperative treatment of low back disorders: differentiated useful from useless therapy. In: Frymoyer JW, Ducker TB, Hadler NM, et al, eds. The Adult Spine: Principles and Practice. Philadelphia, Pa: Lippincott-Raven; 1997:1777-93.
Deyo RA, Bass JE. Lifestyle and low-back pain. The influence of smoking and obesity. Spine. May 1989;14(5):501-6. [Medline].
Deyo RA, Diehl AK, Rosenthal M. How many days of bed rest for acute low back pain? A randomized clinical trial. N Engl J Med. Oct 23 1986;315(17):1064-70. [Medline].
Di Rosa M, Calignamo A, Carnuccio R. Multiple control of inflammation by glucocorticoids. Agents Action. 1986;17:284-9.
Dwyer A, Aprill C, Bogduk N. Cervical zygapophyseal joint pain patterns. I: A study in normal volunteers. Spine. Jun 1990;15(6):453-7. [Medline].
Eisenberg E, Alon N, Ishay A, et al. Lamotrigine in the treatment of painful diabetic neuropathy. Eur J Neurol. Mar 1998;5(2):167-173. [Medline].
Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology. Aug 14 2001;57(3):505-9. [Medline].
Elan Corporation, plc. Ziconamide. Feb 29, 2000.
Farago F. Trigeminal neuralgia: its treatment with two new carbamazepine analogues. Eur Neurol. 1987;26(2):73-83. [Medline].
Felder M. Tizanidine in the treatment of neck and low back pain. Aids Int. 1990;1-9.
Fields HL. Pain. New York, NY: McGraw-Hill; 1987.
Fordyce WE. Behavioral Methods for Chronic Pain and Illnesses. St Louis, Mo: CV Mosby Company; 1975.
Fortin JD, Aprill CN, Ponthieux B, Pier J. Sacroiliac joint: pain referral maps upon applying a new injection/arthrography technique. Part II: Clinical evaluation. Spine. Jul 1 1994;19(13):1483-9. [Medline].
Fortin JD, Dwyer AP, West S, Pier J. Sacroiliac joint: pain referral maps upon applying a new injection/arthrography technique. Part I: Asymptomatic volunteers. Spine. Jul 1 1994;19(13):1475-82. [Medline].
Fortin JD, Kissling RO, O''Connor BL, Vilensky JA. Sacroiliac joint innervation and pain. Am J Orthop. Dec 1999;28(12):687-90. [Medline].
Frith JC, Monkkonen J, Auriola S, et al. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum. Sep 2001;44(9):2201-10. [Medline].
Frost FA, Jessen B, Siggaard-Andersen J. A control, double-blind comparison of mepivacaine injection versus saline injection for myofascial pain. Lancet. Mar 8 1980;1(8167):499-500. [Medline].
Fryda-Kaurimsky Z, Muller-Fassbender H. Tizanidine (DS 103-282) in the treatment of acute paravertebral muscle spasm: a controlled trial comparing tizanidine and diazepam. J Int Med Res. 1981;9(6):501-5. [Medline].
Frymoyer JW. Back pain and sciatica. N Engl J Med. Feb 4 1988;318(5):291-300. [Medline].
Frymoyer JW, Pope MH, Clements JH, et al. Risk factors in low-back pain. An epidemiological survey. J Bone Joint Surg [Am]. Feb 1983;65(2):213-8. [Medline].
Fujiwara A, Lim TH, An HS, et al. The effect of disc degeneration and facet joint osteoarthritis on the segmental flexibility of the lumbar spine. Spine. Dec 1 2000;25(23):3036-44. [Medline].
Fujiwara A, Tamai K, An HS, et al. The relationship between disc degeneration, facet joint osteoarthritis, and stability of the degenerative lumbar spine. J Spinal Disord. Oct 2000;13(5):444-50. [Medline].
Fukui S, Ohseto K, Shiotani M, et al. Distribution of referred pain from the lumbar zygapophyseal joints and dorsal rami. Clin J Pain. Dec 1997;13(4):303-7. [Medline].
Garvey TA, Marks MR, Wiesel SW. A prospective, randomized, double-blind evaluation of trigger-point injection therapy for low-back pain. Sep 1989;14(9):962-4. [Medline].
Gatchel RJ, Mayer TG, Hazard RG, et al. Functional restoration. Pitfalls in evaluating efficacy. Spine. Aug 1992;17(8):988-95. [Medline].
Giles LG, Harvey AR. Immunohistochemical demonstration of nociceptors in the capsule and synovial folds of human zygapophyseal joints. Br J Rheumatol. Oct 1987;26(5):362-4. [Medline].
Gilron I, Booher SL, Rowan JS, Max MB. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin Neuropharmacol. Mar-Apr 2001;24(2):109-12. [Medline].
Goicoechea C, Porras E, Alfaro MJ, Martin MI. Alendronate induces antinociception in mice, not related with its effects in bone. Jpn J Pharmacol. Apr 1999;79(4):433-7. [Medline].
Grob KR, Neuhuber WL, Kissling RO. [Innervation of the sacroiliac joint of the human]. Z Rheumatol. Mar-Apr 1995;54(2):117-22. [Medline].
Gross RJ, Doerr H, Caldirola D, et al. Borderline syndrome and incest in chronic pelvic pain patients. Int J Psychiatry Med. 1980-81;10(1):79-96. [Medline].
Haldeman S. North American Spine Society: failure of the pathology model to predict back pain. Spine. Jul 1990;15(7):718-24. [Medline].
Hall H, Iceton JA. Back school. An overview with specific reference to the Canadian Back Education Units. Clin Orthop. Oct 1983;(179):10-7. [Medline].
Hambly MF, Mooney V. Effect of smoking and pulsed electromagnetic fields on intradiscal pH in rabbits. Spine. Jun 1992;17(6 Suppl):S83-5. [Medline].
Harkins S, Linford J, Cohen J, et al. Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study. J Craniomandib Disord. 1991;5(3):179-86. [Medline].
Hazard RG, Fenwick JW, Kalisch SM, et al. Functional restoration with behavioral support. A one-year prospective study of patients with chronic low-back pain. Spine. Feb 1989;14(2):157-61. [Medline].
Heavner JE, Racz GB, Raj P. Percutaneous epidural neuroplasty: prospective evaluation of 0.9% NaCl versus 10% NaCl with or without hyaluronidase. Reg Anesth Pain Med. May-Jun 1999;24(3):202-7. [Medline].
Helfgott SM. Sensible approach to low back pain. Bull Rheum Dis. 2001;50(3):1-4. [Medline].
Hicks GS, Duddleston DN, Russell LD, et al. Low back pain. Am J Med Sci. Oct 2002;324(4):207-11. [Medline].
Hubbard DR. Chronic and recurrent muscle pain: pathophysiology and treatment, and review of pharmacologic studies. J Musculoskeletal Pain. 1996;4:123-43.
Indahl A, Kaigle AM, Reikeras O, Holm SH. Interaction between the porcine lumbar intervertebral disc, zygapophysial joints, and paraspinal muscles. Spine. Dec 15 1997;22(24):2834-40. [Medline].
Ingram RE, Atkinson JH, Slater MA, et al. Negative and positive cognition in depressed and nondepressed chronic-pain patients. Health Psychol. 1990;9(3):300-14. [Medline].
Inman VT, Saunders JB. Referred pain from skeletal structures. J Nerv Mont Dis. 1944;99:660.
Iwabuchi M, Rydevik B, Kikuchi S, Olmarker K. Effects of anulus fibrosus and experimentally degenerated nucleus pulposus on nerve root conduction velocity: relevance of previous experimental investigations using normal nucleus pulposus. Spine. Aug 1 2001;26(15):1651-5. [Medline].
Jackson RP. The facet syndrome. Myth or reality?. Clin Orthop. Jun 1992;(279):110-21. [Medline].
Jacobson LO, Bley K, Hunter JC, et al. Anti-thermal hyperalgesic properties of antidepressants in a rat model of neuropathic pain [Abstract]. American Pain Society. 1995.
Jain KK. An evaluation of intrathecal ziconotide for the treatment of chronic pain. Expert Opin Investig Drugs. Oct 2000;9(10):2403-10. [Medline].
Jensen MC, Brant-Zawadzki MN, Obuchowski N, et al. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med. Jul 14 1994;331(2):69-73. [Medline].
Kang JD, Evans CH. Cytokines, nitric oxide, prostaglandin E2, and idiopathic low back pain. In: Weinstein JN, Gordan SL, eds. Low Back Pain: A Scientific and Clinical Overview. Rosemount, Ill: American Academy of Orthopedic Surgeons; 1996:529-38.
Kang JD, Georgescu HI, McIntyre-Larkin L, et al. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine. Feb 1 1996;21(3):271-7. [Medline].
Kaplan M. Zonisamide: benefits in chronic pain patients. Paper presented at: AAPM&R. 2002.
Karppinen J, Korhonen T, Malmivaara A, et al. Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica. Spine. Apr 15 2003;28(8):750-3; discussion 753-4. [Medline].
Katz NP. MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients. J Pain Symptom Manage. Jan 2000;19(1 Suppl):S37-41. [Medline].
Kawakami, Chatenia K, Weinstein JN. Anatomy, biochemistry, and physiology of low back pain. In: White AH, Schofferman JA, eds. Spine Care: Diagnosis and Conservative Treatment. 1995:84-103.
Keefe FJ, Bedcham JC, Fillingim. The psychology of chronic back pain In: Frymoyer JW, ed. The Adult Spine: Principles and Practice. 1991:185-197.
Keefe FJ, Gil K, Rose SC. Behavioral approaches in programs and issues. Clin Psychol Rev. 1986;6:87-113.
Keefe FJ, Gil MK, Rose SC. Behavioral approaches in the multidisciplinary management of chronic pain: programs and issues. Clin Psychol Rev. 1986;6:878-113.
Kellgren JH. The anatomical source of back pain. Rheumatol Rehab. 1977;16:3-12.
Kelsey JL, Githens PB, O''Conner T, et al. Acute prolapsed lumbar intervertebral disc. An epidemiologic study with special reference to driving automobiles and cigarette smoking. Spine. Sep 1984;9(6):608-13. [Medline].
Kelsey JL, Githens PB, White AA 3d, et al. An epidemiologic study of lifting and twisting on the job and risk for acute prolapsed lumbar intervertebral disc. J Orthop Res. 1984;2(1):61-6. [Medline].
Kelsey JL, White AA 3d. Epidemiology and impact of low-back pain. Spine. Mar-Apr 1980;5(2):133-42. [Medline].
Killian LE. Psychological barriers to recovery. In: Isernhagen SH, ed. Work Injury Management and Prevention. 18. Gaithersburg Aspe; 1998:66-71.
Klaber Moffett JA, Chase SM, Portek I, Ennis JR. A controlled, prospective study to evaluate the effectiveness of a back school in the relief of chronic low back pain. Spine. Mar 1986;11(2):120-2. [Medline].
Koes BW, Scholten R, Mens JMA et al:. Epidural steroid injections for low back pain and sciatica: An updated systematic review of randomized clinical trials. Pain Digest. 1999;9:241-247.
Krusz J. Levetiracetam: novel agent for refractory neuropathic pain (abstract). Advanced Studies in Medicine. 2001;1:463.
Kunz J, Backonja M. Use of zonisamide in patients with neuropathic pain [Abstract]. Paper presented at: 10th World Congress on Pain. 2002.
Lee PW, Chow SP, Lieh-Mak F, et al. Psychosocial factors influencing outcome in patients with low-back pain. Spine. Aug 1989;14(8):838-43. [Medline].
Lilius G, Laasonen EM, Myllynen P, et al. Lumbar facet joint syndrome. A randomised clinical trial. J Bone Joint Surg [Br]. Aug 1989;71(4):681-4. [Medline].
Lindblom K, Hultqvist G. Absorption of protruded disc tissue. J Bone Joint Surg Am. Jul 1950;32-A(3):557-60. [Medline].
Lindstrom P. The analgesic effect of carbamazepine in trigeminal neuralgia. Pain. (Suppl 4) 1987;S85.
Liu GZ, Ishihara H, Osada R, et al. Nitric oxide mediates the change of proteoglycan synthesis in the human lumbar intervertebral disc in response to hydrostatic pressure. Spine. Jan 15 2001;26(2):134-41. [Medline].
Liu T, van Rooijen N, Tracey DJ. Depletion of macrophages reduces axonal degeneration and hyperalgesia following nerve injury. Pain. May 2000;86(1-2):25-32. [Medline].
Lopez-Trigo J, Serra J, Ortiz P, Sancho J. Topiramate vs amitriptyline on diabetic peripheral neuropathic pain [Abstract]. Advanced Studies in Medicine. 2001;1:460-1.
Lord SM, Barnsley L, Wallis BJ, et al. Percutaneous radio-frequency neurotomy for chronic cervical zygapophyseal-joint pain. N Engl J Med. Dec 5 1996;335(23):1721-6. [Medline].
Lunardi G, Leandri M, Albano C, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology. Jun 1997;48(6):1714-7. [Medline].
Maigne JY, Aivaliklis A, Pfefer F. Results of sacroiliac joint double block and value of sacroiliac pain provocation tests in 54 patients with low back pain. Spine. Aug 15 1996;21(16):1889-92. [Medline].
Manchikanti L, Pampati V, Fellows B, et al. Prevalence of lumbar facet joint pain in chronic low back pain. Pain Physician. 1999;2:59-64.
Manchikanti L, Singh V, Pampati S, et al. Evaluation of the prevalence of facet joint pain in chronic thoracic pain. Pain Physician. 2002;5:354-9.
Manchikanti L, Singh V, Pampati S, et al. Evaluation of the relative contributions of various structures in chronic low back pain. Pain Physician. 2002;4:308-16.
Marks R. Distribution of pain provoked from lumbar facet joints and related structures during diagnostic spinal infiltration. Pain. Oct 1989;39(1):37-40. [Medline].
Matsui H, Olmarker K, Cornefjord M. Local electrophysiologic stimulation in experimental double level cauda equina compression. Spine. Sep 1992;17(9):1075-8. [Medline].
Mayer TG, Gatchel RJ. Functional restoration for spinal disorders. The Sports Medicine Approach. Philadelphia, Pa: Lea & Febiger;1988.
Mayer TG, Gatchel RJ, Mayer H, et al. A prospective two-year study of functional restoration in industrial low back injury. An objective assessment procedure. JAMA. Oct 2 1987;258(13):1763-7. [Medline].
McCall IW, Park WM, O''Brien JP. Induced pain referral from posterior lumbar elements in normal subjects. Spine. Sep-Oct 1979;4(5):441-6. [Medline].
McCarron RF, Wimpee MW, Hudkins PG, Laros GS. The inflammatory effect of nucleus pulposus. A possible element in the pathogenesis of low-back pain. Spine. Oct 1987;12(8):760-4. [Medline].
McNeill T, Warwick D, Andersson G, Schultz A. Trunk strengths in attempted flexion, extension, and lateral bending in healthy subjects and patients with low-back disorders. Spine. Nov-Dec 1980;5(6):529-38. [Medline].
Mendell LM, Wall PD. Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibers. Nature. Apr 3 1965;206:97-9. [Medline].
Mense S. Biochemical pathogenesis of myofascial pain. J Musculoskeletal Pain. 1996;4:145-62.
Messenheimer J, Mullens EL, Giorgi L, Young F. Safety review of adult clinical trial experience with lamotrigine. Drug Saf. Apr 1998;18(4):281-96. [Medline].
Million R, Nilsen KH, Jayson MI, Baker RD. Evaluation of low back pain and assessment of lumbar corsets with and without back supports. Ann Rheum Dis. Oct 1981;40(5):449-54. [Medline].
Mooney V, Robertson J. The facet syndrome. Clin Orthop. Mar-Apr 1976;(115):149-56. [Medline].
Moore RJ, Crotti TN, Osti OL, et al. Osteoarthrosis of the facet joints resulting from anular rim lesions in sheep lumbar discs. Spine. Mar 15 1999;24(6):519-25. [Medline].
Murata Y, Takahashi K, Yamagata M, et al. Origin and pathway of sensory nerve fibers to the ventral and dorsal sides of the sacroiliac joint in rats. J Orthop Res. May 2001;19(3):379-83. [Medline].
Murphey F. Sources and patterns of pain in disc disease. Clin Neurosurg. 1968;15:343-51. [Medline].
Murtagh FR. Computed tomography and fluoroscopy guided anesthesia and steroid injection in facet syndrome. Spine. Jun 1988;13(6):686-9. [Medline].
Myers RR. The pathogenesis of neuropathic pain. Reg Anesth. 1962;31:91-114.
Nachemson A, Schultz A, Andersson G. Mechanical effectiveness studies of lumbar spine orthoses. Scand J Rehabil Med Suppl. 1983;9:139-49. [Medline].
Nachemson AL. Intradiscal measurements of pH in patients. Acta Orthop Scand. 1969;40:23-41.
North American Spine Society's Ad Hoc Committee, Diagnostic and Therapeutic Procedures. Common diagnostic and therapeutic procedures of the lumbosacral spine. The North American Spine Society's Ad Hoc Committee on Diagnostic and Therapeutic Procedures. Spine. Oct 1991;16(10):1161-7. [Medline].
Novak V, Kanard R, Kissel JT, Mendell JR. Treatment of painful sensory neuropathy with tiagabine: a pilot study. Clin Auton Res. Dec 2001;11(6):357-61. [Medline].
Olmarker K, Brisby H, Yabuki S, et al. The effects of normal, frozen, and hyaluronidase-digested nucleus pulposus on nerve root structure and function. Spine. Mar 1 1997;22(5):471-5; discussion 476. [Medline].
Olmarker K, Holm S, Rosenqvist AL, Rydevik B. Experimental nerve root compression. A model of acute, graded compression of the porcine cauda equina and an analysis of neural and vascular anatomy. Spine. Jan 1991;16(1):61-9. [Medline].
Olmarker K, Holm S, Rydevik B. Importance of compression onset rate for the degree of impairment of impulse propagation in experimental compression injury of the porcine cauda equina. Spine. 1990;35:416-9.
Olmarker K, Nordborg C, Larsson K, Rydevik B. Ultrastructural changes in spinal nerve roots induced by autologous nucleus pulposus. Spine. Feb 15 1996;21(4):411-4. [Medline].
Olmarker K, Rydevik B. Pathophysiology of spinal nerve roots as related to sciatica and disc herniation. In: Herkowitz HN, Garfin SR, Balderston RA, et al, eds. Rothman-Simeone Studies: The Spine. Philadelphia, Pa: WB Saunders; 1999:159-72.
Olmarker K, Rydevik B, Holm S. Edema formation in spinal nerve roots induced by experimental, graded compression. An experimental study on the pig cauda equina with special reference to differences in effects between rapid and slow onset of compression. Spine. Jun 1989;14(6):569-73. [Medline].
Olmarker K, Rydevik B, Nordborg C. Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine. Sep 1 1993;18(11):1425-32. [Medline].
Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch C 3rd. Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther. Jan 1998;284(1):208-14. [Medline].
Parke WW, Watanabe R. The intrinsic vasculature of the lumbosacral spinal nerve roots. Spine. Jul-Aug 1985;10(6):508-15. [Medline].
Penn RD, Paice JA. Chronic intrathecal morphine for intractable pain. J Neurosurg. Aug 1987;67(2):182-6. [Medline].
Polatin PB, Kinney RK, Gatchel RJ, et al. Psychiatric illness and chronic low-back pain. The mind and the spine--which goes first?. Spine. Jan 1993;18(1):66-71. [Medline].
Polfliet MM, van de Veerdonk F, Dopp EA, et al. The role of perivascular and meningeal macrophages in experimental allergic encephalomyelitis. J Neuroimmunol. Jan 2002;122(1-2):1-8. [Medline].
Powell MC, Wilson M, Szypryt P, et al. Prevalence of lumbar disc degeneration observed by magnetic resonance in symptomless women. Lancet. Dec 13 1986;2(8520):1366-7. [Medline].
Praemer A, Furnes S, Rice D. Musculoskeletal Conditions in the United States. Park Ride, Ill: American Academy of Orthopedic Surgeons; 1992:1-199.
Probert L, Akassoglou K, Kassiotis G, et al. TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J Neuroimmunol. Feb 1997;72(2):137-41. [Medline].
Racz GB, Heavner JE, Diede JH. Lysis of epidural adhesions utilizing the epidural approach. In: Waldeman SD, Winnie AP, eds. Interventional Pain Management. 1996:339-51.
Racz GB, Heavner JE, Singleton W, et al. Hypertonic saline and corticosteroid injected epidurally for pain control. In: Racz GB, ed. Techniques of Neurology. 1989:73-86.
Redford EJ, Hall SM, Smith KJ. Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain. Aug 1995;118 (Pt 4):869-78. [Medline].
Remillard G. Oxcarbazepine and intractable trigeminal neuralgia. Epilepsia. 1994;35:S50-S53.
Rice AS, Maton S; Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain. Nov 2001;94(2):215-24. [Medline].
Riihimaki H. Back disorders in relation to heavy physical work. [Thesis]. Institute of Occupational Health, Helinski, Finland. 1989;415-23.
Riihimaki H, Wickstrom G, Hanninen K, Luopajarvi T. Predictors of sciatic pain among concrete reinforcement workers and house painters--a five-year follow-up. Scand J Work Environ Health. Dec 1989;15(6):415-23. [Medline].
Rivner MH. The neurophysiology of myofascial pain syndrome. In: Fields HL, ed. Pain. 5. New York, NY: McGraw-Hill; 2000:432-40.
Rizzo JA, Abbott TA 3rd, Berger ML. The labor productivity effects of chronic backache in the United States. Med Care. Oct 1998;36(10):1471-88. [Medline].
Roberts WJ. A hypothesis on the physiological basis for causalgia and related pains. Pain. Mar 1986;24(3):297-311. [Medline].
Rosenberg JM, Harrell C, Ristic H, et al. The effect of gabapentin on neuropathic pain. Clin J Pain. Sep 1997;13(3):251-5. [Medline].
Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. Dec 2 1998;280(21):1837-42. [Medline].
Royal M. Retrospective case series of zonisamide in the treatment of neuropathic pain [Abstract]. Paper presented at: 4th International Conference on the Mechanisms and Treatment of Neuropathic Pain. 2000.
Russell IJ. Neurochemical pathogenesis of fibromyalgia syndrome. J Musculoskeletal Pain. 1996;4:61-92.
Rydevik BL. The effects of compression on the physiology of nerve roots. J Manipulative Physiol Ther. 1992;1:62-6.
Rydevik D, Holm S, Brown MD, et al. Nutrition of spinal nerve roots: the role of diffusion from the cerebral spinal fluid. Trans Orthop Res Soc. 1984;9:276.
Saal JA. The role of inflammation in lumbar pain: physical medicine and rehabilitation. State of the Art Reviews. 1990;4:191-99.
Saal JA, Saal JS, Herzog RJ. The natural history of lumbar intervertebral disc extrusions treated nonoperatively. Spine. Jul 1990;15(7):683-6. [Medline].
Saal JA, Saal JS. Intradiscal electrothermal treatment for chronic discogenic low back pain: prospective outcome study with a minimum 2-year follow-up. Spine. May 1; 2002;27(9):966-73; discussion 973-4. [Medline].
Saal JS, Franson RC, Dobrow R, et al. High levels of inflammatory phospholipase A2 activity in lumbar disc herniations. Spine. Jul 1990;15(7):674-8. [Medline].
Saberski LR. Spinal endoscopy: current concepts. In: Waldman SD, ed. Interventional Pain Management. 2nd ed. Philadelphia: WB Saunders Company; 2000:143-161.
Saberski LR, Brull SJ. Spinal and epidural endoscopy: a historical review. 1: Yale J Biol Med. Jan-Apr 1995;68(1-2):7-15. [Medline].
Sakamoto N, Yamashita T, Takebayashi T, et al. An electrophysiologic study of mechanoreceptors in the sacroiliac joint and adjacent tissues. Spine. Oct 15 2001;26(20):E468-71. [Medline].
Sang CN. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials. J Pain Symptom Manage. Jan 2000;19(1 Suppl):S21-5. [Medline].
Schofferman J. Use and abuse of medications. Non-operative care of lumbar pain syndromes. North American Spine Society and Seton Medical Center, Boston, MA. 1992;97-100.
Schofferman JA. Applied neurophysiology of pain. In: White AH, Schofferman JA, eds. Spine Care: diagnosis and conservative treatment. St Louis, Mo: Mosby Press;. 1995: 23-6.
Schwarzer AC, Aprill CN, Bogduk N. The sacroiliac joint in chronic low back pain. Spine. Jan 1 1995;20(1):31-7. [Medline].
Schwarzer AC, Aprill CN, Derby R, et al. Clinical features of patients with pain stemming from the lumbar zygapophysial joints. Is the lumbar facet syndrome a clinical entity?. Spine. May 15 1994;19(10):1132-7. [Medline].
Schwarzer AC, Aprill CN, Derby R, et al. The relative contributions of the disc and zygapophyseal joint in chronic low back pain. Spine. Apr 1 1994;19(7):801-6. [Medline].
Schwarzer AC, Wang SC, Bogduk N, et al. Prevalence and clinical features of lumbar zygapophysial joint pain: a study in an Australian population with chronic low back pain. Ann Rheum Dis. Feb 1995;54(2):100-6. [Medline].
Selby DK. The structural degenerative cascade: The lumbar spine. In: White AH, Schofferman JA, eds. Spine Care: Diagnosis and Conservative Treatment. 1995:8-16.
Shekelle PG. Spinal manipulation. Spine. Apr 1 1994;19(7):858-61. [Medline].
Simmons JW, Avant WS, Demski J, Parisher D. Determining successful pain clinic treatment through validation of cost effectiveness. Spine. Mar 1988;13(3):342-4. [Medline].
Simons DG, Travell JG, Simons LS. Myofascial pain and dysfunction: the trigger point manual. 2nd ed. 1999.
Simpson DM, Olney R, McArthur JC, et al. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology. Jun 13 2000;54(11):2115-9. [Medline].
Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. Dec 1999;83(3):389-400. [Medline].
Slipman CW, Huston CW. Diagnostic sacroiliac joint injections. In: Manchikanti L, Slipman CW, Fellows B, eds. Interventional Pain Management: Low Back Pain - Diagnosis and Treatment. Paducah, KY: ASIPP Publishing; 2002:269-74.
Slipman CW, Jackson HB, Lipetz JS, et al. Sacroiliac joint pain referral zones. Arch Phys Med Rehabil. Mar 2000;81(3):334-8. [Medline].
Smith PA, Moran TD. The nociceptin receptor as a potential target in drug design. Drug News Perspect. Aug 2001;14(6):335-45. [Medline].
Snook SH. Low back pain in industry. American Academy of Orthopaedic Surgeons Symposium on Idiopathic Low Back Pain. 1982:23-38.
Sorkin LS, Xiao WH, Wagner R, et al. TNF-alpha applied to the sciatic nerve trunk elicits background firing in nociceptive primary afferents fibers. 8th world congress for pain, IASP abstracts, Vancouver, IASP Press. Aug 1996;354.
Tai Q, Kirshblum S, Chen B, et al. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J Spinal Cord Med. 2002;25(2):100-5. [Medline].
Taylor K, Rowbotham MC. Venlafaxine for chronic pain. American Pain Society Annual meeting 1995; 95726 [Abstract].
Thompson RE, Pearcy MJ, Downing KJ, et al. Disc lesions and the mechanics of the intervertebral joint complex. Spine. Dec 1 2000;25(23):3026-35. [Medline].
Thompson TL, Byyny RL. Pain problems in primary care medical practice. Handbook of Chronic Pain Management. 1989:532-59.
Tse FLS, Jaffe JM, Bhuta S. Pharmacokinetics of tizanidine in health volunteers. Fundam Clin Pharmacol. 1987;1:479-88.
Tunali D, Jefferson JW, Geist JH. Depression and Antidepressants: A Guide. Madison, WI: Information Centers, Madison Institute of Medicine; 1999.
van Tulder MW, Scholten RJ, Koes BW, Deyo RA. Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine. Oct 1 2000;25(19):2501-13. [Medline].
van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine. Sep 1 2003;28(17):1978-92. [Medline].
Vestergaard K, Andersen G, Gottrup H, et al. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. Jan 23 2001;56(2):184-90. [Medline].
Vilensky JA, O''Connor BL, Fortin JD, et al. Histologic analysis of neural elements in the human sacroiliac joint. Spine. Jun 1 2002;27(11):1202-7. [Medline].
Waddell G. 1987 Volvo award in clinical sciences. A new clinical model for the treatment of low-back pain. Spine. Sep 1987;12(7):632-44. [Medline].
Waddell G, McCulloch JA, Kummel E, Venner RM. Nonorganic physical signs in low-back pain. Spine. Mar-Apr 1980;5(2):117-25. [Medline].
Wagner R, Myers RR. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport. Nov 25 1996;7(18):2897-901. [Medline].
Wagstaff AJ, Bryson HM. Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders. Drugs. Mar 1997;53(3):435-52. [Medline].
Waldman SD. Recent advances in analgesic therapy - tizanidine. Pain Digest. 1999;9:40-3.
Watson CP. The treatment of neuropathic pain: antidepressants and opioids. Clin J Pain. Jun 2000;16(2 Suppl):S49-55. [Medline].
Weinreb JC, Wolbarsht LB, Cohen JM, et al. Prevalence of lumbosacral intervertebral disk abnormalities on MR images in pregnant and asymptomatic nonpregnant women. Radiology. Jan 1989;170(1 Pt 1):125-8. [Medline].
Weinstein J, Claverie W, Gibson S. The pain of discography. Spine. Dec 1988;13(12):1344-8. [Medline].
Weinstein JN. The role of neurogenic and non-neurogenic mediators as they relate to pain and the development of osteoarthritis. A clinical review. Spine. Oct 1992;17(10 Suppl):S356-61. [Medline].
Wheeler AH. Diagnosis and management of low back pain and sciatica. Am Fam Physician. Oct 1995;52(5):1333-41, 1347-8. [Medline].
Wheeler AH. Evolutionary mechanisms in chronic low back pain and rationale for treatment. Am J Pain Management. 1995;5:62-66.
Wheeler AH, Aaron GW. Muscle pain due to injury. Curr Pain Headache Rep. Oct 2001;5(5):441-6. [Medline].
Wheeler AH, Hanley EN Jr. Nonoperative treatment for low back pain. Rest to restoration. Spine. Feb 1 1995;20(3):375-8. [Medline].
Wheeler AH, Murrey DB. Chronic lumbar spine and radicular pain: pathophysiology and treatment. Curr Pain Headache Rep. Apr 2002;6(2):97-105. [Medline].
Wickstrom G, Hanninen K, Lehtinen M, Riihimaki H. Previous back syndromes and present back symptoms in concrete reinforecment workers. Scand J Work Environ Health. 1978;4 Suppl 1:20-9. [Medline].
Wiesel SW, Tsourmas N, Feffer HL, et al. A study of computer-assisted tomography. I. The incidence of positive CAT scans in an asymptomatic group of patients. Spine. Sep 1984;9(6):549-51. [Medline].
Windsor RE, King FJ, Roman SJ, et al. Electrical Stimulation Induced Lumbar Medial Branch Referral Patterns. Pain Physician. 2002;5:405-18.
Wu WP, Hao JX, Ongini E, et al. A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury. Br J Pharmacol. Jan 2004;141(1):65-74. [Medline].
Yao MZ, Gu JF, Wang JH, et al. Interleukin-2 gene therapy of chronic neuropathic pain. Neuroscience. 2002;112(2):409-16. [Medline].
Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. Nov 1997;73(2):223-30. [Medline].
Zakrzewska JM, Patsalos PN. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia. J Neurol Neurosurg Psychiatry. Apr 1989;52(4):472-6. [Medline].
Zeilhofer HU, Calo G. Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy?. J Pharmacol Exp Ther. Aug 2003;306(2):423-9. [Medline].
Further Reading
Keywords
back pain, chronic back pain, lower back pain, LBP, chronic low back pain, cLBP, chronic lumbar pain, lumbar pain, lumbar spine pain, degeneration of the spine, spinal degeneration, back trauma, spine trauma, trauma of the spine, spinal trauma, chronic lumbago, chronic lumbar muscle spasm, lumbar disc degeneration and spondylosis, lumbar segmental degeneration and instability with concomitant soft tissue dysfunction, myofascial pain syndrome, fibrositis, inflammatory spondyloarthropathy, metabolic bone disease

